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The Influence of Modality on the Antihypertensive Effects of Exercise: A Meta-Analysis 
Hayley V. MacDonald, PhD 
University of Connecticut, 2015 
Background: Over 80 million adults in the United States have hypertension (~33%); of those, less 
than half are adequately controlled. Regular participation in exercise is one of the most important 
modifiable risk factor in the prevention, treatment, and control of hypertension. The antihypertensive 
effects of exercise have been studied extensively, concluding that aerobic exercise training (AET) 
and dynamic resistance training (RT) lowers blood pressure (BP) 5-7 and 2-3 mmHg among adults 
with hypertension. Nonetheless, BP reductions with AET and RT (~1-9 and ~0-6 mmHg) vary 
widely, highlighting the significant variability in the training response. Patient and exercise 
characteristics may explain these differences; however, what patient profile and exercise features 
elicits optimal BP benefit remains unclear. Therefore, we performed two high-quality meta-analyses 
that adhered to contemporary standards to determine the effectiveness of AET and RT as stand-alone 
antihypertensive therapy and identify what patient profile and exercise ‘dose’ elicited optimal 
antihypertensive therapy. Methods: Electronic databases identified 84 and 64 controlled AET (105 
interventions) and RT (71 interventions) trials that involved adults ≥19yr and reported BP pre- and 
post-intervention. Analyses followed random-effects assumptions. Results: Participants were White, 
middle-aged, overweight adults with prehypertension. Moderate-to-vigorous intensity AET and 
moderate-intensity RT performed ~3-4 d·wk-1 for 14-18 wks reduced systolic BP (SBP)/diastolic BP 
(DBP) ~4/3 mmHg and ~3/2 mmHg versus controls (ps<0.01). Greater BP reductions occurred 
among AET and RT samples with higher resting BP: ~7/6 and ~6/5 mmHg for hypertension, ~5/4 
and ~3/3 mmHg for prehypertension, ~3/1 and ~0/1 mmHg for normal BP (ps≤0.03). For AET, BP 
was reduced to the greatest extent among non-White samples with hypertension that achieved the 
largest fitness gains and performed the highest volumes of AET (-12.0/-12.2 mmHg), twice the  
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magnitude observed for White samples (-6.8/-6.3 mmHg). Similarly, dynamic RT reduced BP to the 
greatest extent among non-White samples with hypertension (-14.3/-10.3 mmHg), reductions 
approximately twice the magnitude previously reported following AET. Discussion: These results 
highlight the critical need for more precise exercise prescriptions that maximize the effectiveness of 
AET and RT as viable stand-alone or combined antihypertensive therapeutic exercise options among 
racially/ethnically diverse samples with hypertension. 
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 Chapter 1  
Introduction 
1.1 Background and Significance 
Cardiovascular disease (CVD) causes 17.3 million global deaths annually, which represents 
approximately one-third (~30%) deaths worldwide [1, 2]. CVD-mortality follows a similar pattern in 
the United States (US). It is responsible for one of every three US deaths (~76 million) making it one 
of the leading causes of mortality [2]. In 2013, over 40% of all CVD-related deaths were attributed to 
high blood pressure (BP) [2]. In addition to hypertension, approximately 85% of US adults have at 
least one other CVD risk factor [3].  
Hypertension is a major risk factor for CVD [2]. Hypertension leads to an estimated 9.4 
million annual deaths worldwide, which is about as many deaths that result from all infectious 
diseases combined [1]. Nearly ~33% (80 million) of US adults currently have hypertension (systolic 
BP [SBP] ≥140 mmHg or diastolic [DBP] ≥90 mmHg) [2]; ~6% higher than the Healthy People 2020 
goal of 26.9% of US adults with hypertension [4, 5]. By 2030, this number is projected to reach 
41.1%, an increase in hypertension prevalence of 8.4% [2, 4]. Another 68 million US adults 
(~36.3%) have prehypertension (SBP 120-139 mmHg or DBP 80-89 mmHg) [2], and are at increased 
risk for developing hypertension, incident stroke, myocardial infarction, and CVD [2, 6]. If 
prehypertension is left untreated it will progress rapidly to hypertension [2, 7]. The residual lifetime 
risk for developing hypertension is 90%, making it one of the most prevalent, modifiable, and costly 
CVD risk factors [2]. In 2011, the direct and indirect cost of hypertension totaled $46.4 billion. 
Based on the current trends, in 2030 these costs are expected to reach ~$274 billion in total medical 
expenditures [2]. 
Over the last decade (1999-2012), hypertension treatment (77% versus 60%) and control 
(52% versus 32%) in the US have improved, whereas hypertension prevalence has remained 
unchanged (30-32%) [4]. Several modifiable risk factors have been identified in the prevention, 
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treatment, and control of hypertension, an important one being regular participation in exercise [2, 4, 
7-10]. Lifestyle-related factors were recently identified as the only modifiable determinants of 
hypertension [4]; therefore, more intensive efforts should be focused on promoting these strategies to 
reduce the significant public health burden of hypertension [2]. 
1.2 Exercise Recommendations for Hypertension: The Frequency, Intensity, Time and Type of 
the Exercise Prescription  
Many randomized control trials (RCTs) have investigated the antihypertensive effects of 
exercise, and in turn, over 33 meta-analyses have been published to date [11, 12]. Collectively, these 
meta-analyses concluded that aerobic training (AET) lowers blood pressure (BP) 5-7 mmHg [9, 13, 
14], while dynamic resistance training (RT) lowers BP 2-3 mmHg [9, 14-17] among adults with 
hypertension. Accordingly, the American College of Sports Medicine (ACSM) [9] and other 
professional organizations and committees [8, 10, 18-20] recommend 30-60 minutes of moderate 
intensity (i.e., 40% to <60% maximal oxygen consumption) AET on most days of the week [8-10, 
18, 20] supplemented by moderate-intensity dynamic RT on ≥2 days∙week-1 [8, 9, 20] for the 
prevention, treatment, and control of hypertension.  
1.3 The Meta-Analytic Evidence Regarding the Antihypertensive Effects of Exercise 
Despite the general consensus that exercise, particularly AET, lowers resting BP, a more 
recent and critical review of this literature revealed considerable variability in the magnitude of the 
BP reductions following both AET (i.e., 1-9 mmHg) [12] and dynamic RT (i.e., 0-6 mmHg) [9, 16, 
21, 22] for reasons that are not clear [8, 12]. Investigators conducting RCTs often report aggregate-
level data with standard deviations exceeding the mean BP change of the sample [23]. Furthermore, 
~20-25% of individuals do not lower BP with exercise [24, 25], highlighting the significant inter-
variability in the BP response to exercise training [9, 26, 27]. 
Reasons for inter- and intra-individual variability are not well understood but may be 
partially attributable to differences in baseline sample and exercise intervention characteristics such 
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as the Frequency, Intensity, Time or Type or FITT of the exercise prescription (Ex Rx). Nonetheless, 
few meta-analyses have documented significant moderation patterns pertaining to these 
characteristics with the exception of resting BP or BP status (i.e., normal, prehypertension and 
hypertension) [13, 28-40]. The absence of moderation patterns in the exercise and hypertension 
literature may be attributed to earlier meta-analyses [29, 36-38, 41, 42] being underpowered to 
perform moderator analysis due small samples (<10 trials), or because meta-analyses have used 
statistical approaches that lack the sensitivity to detect exercise-related changes in BP.  
More recent meta-analyses [13, 28, 30, 31, 43, 44] with a greater number of included trials 
(≥28 trials) do not bear this limitation. In addition, the authors of more recent meta-analyses have 
also had access to standard reporting guidelines [45-47] and to more sophisticated meta-analytic 
techniques to estimate the exercise-related changes in BP. Theoretically, more recent meta-analyses 
should be able to calculate and combine effect size estimates from different studies more precisely 
and investigate heterogeneity to a greater extent [47-49]. Conventional meta-analytic techniques, 
such as meta-regression, and more complex analyses using multiple moderator models and the 
moving constant technique should be able to more accurately quantify the influence of sample and 
FITT characteristics and their interaction on resting BP [11, 50-55]. Furthermore, the moving 
constant technique can be used to estimate BP effects at different moderator levels to provide greater 
clinical translation [54]. 
It is clear that the science of meta-analysis has continued to grow and become more advanced 
[48, 49]. Taken together, it is reasonable to assume carefully conducted meta-analyses that pursue 
higher quality methods (e.g., Preferred Reporting Items for Systematic Reviews and Meta-analyses or 
PRISMA [56]) should be able to identify what sample characteristics and ‘dose’ of exercise yields 
the greatest antihypertensive benefits. Yet, the majority of meta-analyses evaluating the 
antihypertensive effects of exercise still fail to fulfill the requirements of the PRISMA reporting 
checklist [11, 56-58] which in turn, threatens the validity and clinical translation of their findings.  
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1.3.1 Reporting Standards for Meta-Analyses 
 Systematic reviews and meta-analyses often serve as pillars of scientific statements, exercise 
recommendations, and clinical guidelines [56-58]. Therefore, progressively more rigorous standard 
reporting practices have been published to improve the overall quality of meta-analyses, focusing on 
the consistency and transparency of reporting procedures [45, 46, 59-62]. The QUality Of Reporting 
Of Meta-analyses (QUOROM) statement was first published in 1999 [45], and has been updated 
twice since then: with the PRISMA Statement in 2009 [46], and more recently with the 2015 
PRISMA-P Statement [56, 63].   
Johnson and colleagues [11] recently reviewed the methodological quality of 33 published 
meta-analyses that examined the effects of exercise on BP. They found more recent meta-analyses 
achieved higher quality scores, but none completely satisfied contemporary quality standards [11]. 
The majority of meta-analyses did not provide adequate information related to their search methods 
or duplicate efforts for study selection and data extraction. Further, few meta-analyses documented 
the scientific quality of included trials, how study quality interacted with their findings, or discussed 
the scientific quality of the included studies in relation to their conclusions [11, 55, 61, 64]. 
Departure from these contemporary reporting standards [47, 56, 63] may contribute further to the 
poor understanding of how important moderators, in particular the sample clinical characteristics, the 
‘dose’ of exercise (i.e., FITT of the Ex Rx), and other study features influence the antihypertensive 
effects of exercise. 
1.4 The Blood Pressure Response to Aerobic Exercise Training  
Approximately 27 meta-analyses have examined the effects of AET on resting BP [11]. 
Given the volume of data, the ACSM classified the BP lowering effects of AET as Category A level 
of evidence, meaning there was “overwhelming data from RCTs provided a consistent pattern of 
findings regarding the effects of AET on resting BP” [9]. On average, the participants in these meta-
analyses were White, middle-aged men and women with prehypertension who performed AET 3 
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days·week-1 for 40 min·session-1 at 65% of maximal oxygen consumption (VO2max) for 16 weeks. 
This dose of aerobic exercise reduced BP 2-3 mmHg among samples with normal BP and 5-7 mmHg 
among samples with hypertension [9].   
 Although these meta-analyses confirmed that the greatest antihypertensive benefits are 
experienced by samples with higher baseline BP, they have not consistently identified other 
moderation patterns, nor have they completely satisfied contemporary quality standards [11, 46, 64]. 
Only three meta-analyses to date reported that race/ethnicity [44], age [65], sex/gender [31], and 
aspects of the FIT [14, 65] influenced the BP reductions following AET. Whelton and colleagues 
[44] found that AET reduced resting SBP/DBP to greater levels among Asian (6/7 mmHg) and Black 
(11/3 mmHg) compared to White samples (3/3 mmHg, p<0.05), while Hayashino and colleagues 
[65] observed that AET reduced SBP to greater levels among adults aged ≥60 yrs (~5 mmHg) than 
<60 yrs (~1 mmHg); and Cornelissen and Smart [31] found that AET was more effective at lowering 
resting BP among samples involving all men (3-5 mmHg) than all women (~1 mmHg).  
In addition, Hayashino et al. [65] and Cornelissen et al. [31] identified FIT characteristics 
that maximized the BP reductions following AET but with conflicting results. Hayashino et al. [65] 
reported that greater reductions in BP occurred with longer duration (≥45 min·session-1) AET (~4 
mmHg); whereas Cornelissen et al. [31] found shorter duration (30-45 min·session-1) AET to be 
more effective (~3-4 mmHg). In addition, Cornelissen and Smart [31] also reported that AET 
performed at moderate-to-vigorous than low intensity and <210 min∙week-1 than >210 min∙week-1 of 
AET elicited the greatest BP reductions. Unfortunately, meta-analyses have not routinely identified 
moderator patterns, and in the few instances that they have, they are not consistent across meta-
analyses [9, 11, 12, 24, 26] and in some cases they conflict [14, 65]. Collectively, these limitations 
highlight the paucity of evidence to support a more personalized approach to the Ex Rx for adults 
with hypertension.  
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 To date, few meta-analyses have attempted to quantify the level of heterogeneity among 
included trials, and rarely have they been able to explain BP variability through moderator analysis 
[31, 44, 65]. The inability of meta-analyses to explain inconsistencies in the BP response following 
AET may be attributed to the poor reporting of sample and FIT characteristics in the literature itself, 
or the limited statistical methods that have been used to investigate heterogeneity. The majority of 
meta-analyses have performed moderator analysis using subgroups despite the availability of 
conventional meta-analytic techniques (i.e., meta-regression) and more sophisticated approaches that 
involve multiple moderator models [53, 66]. Subgroup analysis, a statistical procedure similar to 
analysis of variance (i.e., ANOVA), is most appropriate for research questions focused on analyzing 
the differences among group means, which may have lacked the sensitivity and precision needed to 
detect exercise-related changes in BP [67, 68]. Unlike meta-regression, subgroup analysis does not 
allow for multiple moderators to be examined together [69], and furthermore, it is not suitable for 
more complex moderator analysis involving the moving constant technique [54]. The moving 
constant technique can estimate BP changes at levels of individual moderators (i.e., sample and FIT 
characteristics), to enhance the clinical translation of the findings [54].  
In sum, the limitations stated above have precluded a comprehensive meta-analytic 
investigation of the antihypertensive effects of AET. Meta-analyzing all of the available literature 
using more sophisticated meta-analytic techniques, such as meta-regression and the moving constant 
technique, will allow for increased precision in estimating the effect of how sample and FIT 
characteristics, and their interactions modulate the BP response to AET.  
1.5 The Blood Pressure Response to Dynamic Resistance Training 
In the 2004 position stand on exercise and hypertension, the ACSM [9] graded the level of 
evidence supporting the BP lowering effects of dynamic RT as Category B, meaning there were “few 
randomized trials that existed which are small in size and the results were inconsistent.” Thus, the 
ACSM recommends individuals with hypertension perform dynamic RT as a supplement to AET [9]. 
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At that time, few RCTs had investigated the BP response to dynamic RT and with conflicting results. 
The BP lowering effects of dynamic RT were diverse, with BP reductions ranging from ~5-14 
mmHg for SBP and ~2-8 mmHg for DBP [70-73]. However, there were also trials that did not report 
BP reductions following dynamic RT [70, 72-75], and trials that observed large BP reductions for 
both exercise and control groups [70, 72-77]. Furthermore, only two meta-analyses had been 
conducted on the BP response to RT [37, 42] that included samples of middle-aged, White men with 
normal BP to prehypertension.  
Since then, additional RCTs and meta-analyses have been conducted to examine the BP 
response to dynamic RT [14-17, 21, 22]. Nonetheless, in contrast to the high-level of evidence 
supporting the BP-lowering effects of AET [12], there is much weaker evidence supporting the 
efficacy of RT as a viable therapeutic option to lower BP among adults with hypertension that is 
primarily based on the findings of six meta-analyses [12, 14-17, 21, 22]. Surprisingly, these meta-
analyses included mostly healthy adults with normal BP and prehypertension. Collectively, these 
meta-analyses concluded that dynamic RT lowers BP by 2-3 mmHg independent of resting BP 
values [9]. However, two meta-analyses by Kelley et al. [21] and Cornelissen et al. [16] reported 
larger reductions of 4-6 mmHg, rivaling the magnitude of the reductions reported for individuals with 
hypertension following AET [9]. Both Kelley et al. [21] and Cornelissen et al. [16] included the 
smallest number of RT trials (~9) and participants (~259 to 290) compared to the previous meta-
analyses, that ranged from 11 [15] to upwards of 28 RT trials [14, 17] with samples sizes of 320 [15] 
to 1,012 participants [14, 17]. A smaller number of available trials may have resulted in less 
precision when estimating the BP lowering effects of dynamic RT.  
In contrast to AET, meta-analyses investigation the BP response to dynamic RT have yet to 
identify any moderators of the BP changes following dynamic RT. The absence of moderator 
variables to date may be attributed to the small number of available trials (~9-25), wide ranges in the 
FIT of dynamic RT program, and use of subgroup analysis with categorical variables rather than 
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more sophisticated techniques such as meta-regression with continuous variables to investigate 
potential moderators. Meta-analysis can be a valuable tool for researchers, especially in small bodies 
of literature with disparate results [50, 52, 78, 79]. However, the advantages of meta-analysis over 
the primary literature are only realized if proper statistical approaches are undertaken, and 
researchers adhere to high quality contemporary standards for conducting and reporting for meta-
analyses [11, 56, 61, 64].  
Nonetheless, none of the meta-analysis conducted to date have completely satisfied 
contemporary methodological study quality standards [11, 56, 64], nor have they been able to 
identify important patient or RT characteristics that modulated the BP response to dynamic RT. 
Collectively, these observations suggest that the antihypertensive effects of RT may have been 
underestimated, and they call into question the generalizability of this weak and limited literature to 
adults with hypertension [11, 12].  
1.6 Statement of the Problem 
Despite the large number of RCTs and meta-analyses that have examined the BP lowering 
effects of exercise, little is known about how sample and FITT exercise characteristics may modulate 
BP changes following exercise. In general the existing literature supports: 1) BP can be reduced 
following AET and dynamic RT but the magnitude of the BP response varies considerably across 
trials and modality [12]; 2) sample characteristics may account for some of this variability but meta-
analyses have yet to adequately analyze these effects [9, 11, 12, 55]; 3) the ‘dose’ of exercise or FITT 
characteristics may also account for some of the variability in the BP response but meta-analyses to 
date have not consistently found these variables to influence BP changes following exercise training 
[9, 11, 12]; and last, 4) most meta-analyses have not satisfied contemporary standards [11], most 
notably, failing to document the study quality of included trials and determine whether quality 
independently or interactively influenced their findings [55]. It is possible that low methodological 
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quality trials have suppressed dose-response patterns and moderator variables, and these patterns will 
emerge more clearly in higher methodological quality trials.  
1.7 Specific Aims and Hypotheses 
Therefore, this dissertation proposes to perform two meta-analyses that adhere to high 
quality, contemporary methodological standards to address the current limitations of the existing 
literature: 
 Specific aim 1: To meta-analyze the existing AET literature with high quality methods to 
determine the effectiveness of AET as an antihypertensive therapy and identify what patient clinical 
and AET characteristics elicit optimal antihypertensive BP benefit.  
Hypothesis 1: Patient clinical (i.e., age, body mass index, sex/gender, race/ethnicity, BP medication 
use, etc.) and AET FIT characteristics will moderate the antihypertensive effects of AET.  
Alternative Hypothesis 1: Patient clinical and AET FIT characteristics will not moderate the 
antihypertensive effects of AET.  
 Specific aim 2: To meta-analyze the existing dynamic RT literature with high quality 
methods to determine the effectiveness of RT as stand-alone antihypertensive therapy and identify 
important moderators (i.e., patient clinical and RT FIT characteristics) of the BP response to provide 
insight into the optimal dose of RT to lower BP among adults with hypertension.  
Hypothesis 2: Patient clinical (i.e., age, body mass index, sex/gender, race/ethnicity, BP medication 
use, etc.) and RT FIT characteristics will moderate the antihypertensive effects of dynamic RT and 
provide insight into the optimal dose of RT as stand-alone antihypertensive therapy for adults with 
hypertension 
Alternative Hypothesis 2: Patient clinical and RT FIT characteristics will not moderate the 
antihypertensive effects of dynamic RT. 
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1.8 Clinical Significance 
In total, over 33 meta-analyses have been published to date [11, 12]. Collectively, these meta-
analyses included primarily White middle aged men and women adults with normal BP to stage-1 
hypertension and variables related to race/ethnicity and BP medication use were poorly reported. 
Meta-analyses concluded that exercise training can lower BP among adults with normal to stage-1 
hypertension but that the magnitude of BP reductions were specific to modality: AET can lower BP 
2-3 mmHg among individuals with normal BP and 5-7 mmHg among individuals with hypertension 
[9, 13, 14], and dynamic RT can lower BP ~1-3 mmHg, independent of resting BP values [9, 14-17]. 
It is clear that BP reductions vary widely by modality, however, the influence of sample or FITT 
characteristics or their interaction on resting BP are still poorly understood [31, 44, 65].  
 There is little meta-analytic evidence to support that sample characteristics (i.e., age, 
sex/gender, race/ethnicity, antihypertensive medication use, etc.) influence the BP response to 
exercise [9]. Therefore the ACSM [9] recommends a generic Ex Rx of primarily aerobic exercise 
most days of the week supplemented by dynamic RT 2-3 days·week-1 to treat, prevent, and control 
hypertension. However, ~20-25% of individuals do not lower BP with exercise [24, 25], and there is 
considerable individual variability in this response [9, 23-26]. Reasons for inter- and intra-individual 
variability are not clear but suggest that an individualized approach to the Ex Rx for individuals with 
hypertension may provide greater antihypertensive effects than the current recommendations do. 
Nonetheless, meta-analyses to date have contributed little to our understanding of how important 
moderators, in particular the sample clinical characteristics, the ‘dose’ of exercise (or FITT), and 
other study features influence the antihypertensive effects of exercise. Knowledge of these features 
can, in turn, better inform exercise guidelines and recommendations regarding the antihypertensive 
effects of exercise for policy makers, health care providers, and exercise professionals and increase 
the clinical utility of and adherence to exercise as an antihypertensive lifestyle therapy.  
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Abstract 
Aerobic exercise training (AET) is recommended as antihypertensive lifestyle therapy because it 
lowers blood pressure (BP) 5-7 mmHg among most adults with hypertension. Yet due to significant 
inter-variability in the BP response to AET, it is unclear what types of patient populations would 
benefit most from AET as antihypertensive therapy. The purpose of our meta-analysis was to identify 
what patient and exercise features elicit the largest BP benefits. Electronic databases identified 84 
controlled AET trials (105 interventions) that involved adults ≥19 yr and reported BP pre- and post-
AET. Analyses followed random-effects assumptions. Participants (n=3,634) were White (18% non-
White), middle-aged (47.9±12.9yr), overweight (27.6±3.3 kg·m-2) adults with prehypertension 
(systolic BP [SBP]/diastolic BP [DBP]: 130.8±12.7/81.6±9.0 mmHg). AET performed at moderate-
to-vigorous intensity (5.9±1.7 metabolic equivalents [MET]) for 44.4±23.7 min·session-1, 3.5±1.1 
d·wk-1 for 18.3±16.6 wks reduced SBP (d+=-0.37; 95% CI: -0.48, -0.27; -3.5 mmHg) and DBP 
(d+= -0.35; 95% CI: -0.45, -0.24; -2.7 mmHg) compared to control. Greater BP reductions occurred 
among samples with higher resting BP: ~7/6 mmHg for hypertension, ~5/4 mmHg for 
prehypertension, and ~3/1 mmHg for normal BP (p=0.033/0.019 SBP/DBP, respectively). Moderate-
to-vigorous intensity AET conferred the greatest BP reductions among non-White samples with 
hypertension that achieved the largest physical fitness gains and performed the highest volumes of 
AET (-12.0 mmHg, 95% CI: -15.1, -8.7/-12.2 mmHg, 95% CI: -15.5, -8.9), reductions nearly twice 
that observed for White samples (-6.8 mmHg, 95% CI: -9.4, -4.2/-6.3 mmHg, 95% CI: -8.8, -3.7). 
These results highlight that critical need for more precise exercise prescriptions that maximize the 
effectiveness of AET as antihypertensive therapy for certain patient populations.  
 
Key words: Blood Pressure; Hypertension; Lifestyle Intervention; Systematic Review  
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Introduction 
Hypertension is the most prevalent, modifiable, and costly cardiovascular disease risk factor 
(CVD) [1]. Aerobic exercise training (AET) is universally recommended as first line 
antihypertensive lifestyle therapy due to the strong level of evidence supporting it lowers blood 
pressure (BP) 5-7 mmHg among most adults with hypertension [2]. Therefore, the American College 
of Sports Medicine [2] and other professional organizations and committees [3-7] recommend 30-60 
minutes of moderate intensity (i.e., 40% to <60% maximal oxygen consumption) AET on most days 
of the week for the prevention, treatment, and control of hypertension. Nonetheless, the resultant BP 
reductions from these recommendations range widely from 1-9 mmHg [8], highlighting the 
significant inter-variability in the BP response to AET [2, 9, 10]. 
Over 33 meta-analyses have been conducted to summarize the antihypertensive effects of 
exercise, of which 27 have focused on AET [11]. None of these meta-analyses completely satisfied 
contemporary quality standards [11-13], and most failed to identify whether patient (i.e., resting BP, 
race/ethnicity, sex/gender, etc.) or aerobic exercise characteristics (i.e., the Frequency, Intensity, and 
Time or FIT) modulated the BP response to AET. Only three meta-analyses to date have reported that 
race/ethnicity [14], sex/gender [15], age [16], and aspects of the FIT [16, 17] influenced the BP 
reductions following AET, and these three meta-analyses each found different patterns. For example, 
Whelton and colleagues [14] found that AET reduced resting systolic BP (SBP)/diastolic BP (DBP) 
to greater levels among Asian (6/7 mmHg) and Black (11/3 mmHg) compared to White samples (3/3 
mmHg, p<0.05), while Hayashino and colleagues [16] observed that AET reduced SBP to greater 
levels among adults aged ≥60 yrs (~5 mmHg) than <60 yrs (~1 mmHg), and Cornelissen and Smart 
[15] reported that AET reduced BP to a greater extent among samples of all men (~3-5 mmHg) than 
all women (~1 mmHg). In addition, Hayashino et al. [16] reported greater BP reductions (~4 mmHg) 
following longer duration (≥45 min·session-1) AET, whereas Cornelissen et al. [15] found shorter 
duration (30-45 min·session-1) AET elicited greater BP reductions (~3-4 mmHg).  
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Despite the strong level of evidence to support the antihypertensive effects of AET, there is 
significant inter- and intra-variability in the magnitude of reported BP reductions that result from 
AET ranging from 1-9 mmHg [8, 11], and meta-analyses have been unable to identify consistent 
patterns in what patient and exercise features result in optimal BP benefit. Reasons for these 
discrepancies are not clear, but may partially reside in the fact the volume of available literature is 
continually increasing, or the inability of past meta-analyses to adequately explore high levels of 
heterogeneity that arise from combining trials with widely varying sample and exercise intervention 
characteristics. 
Therefore, we performed a meta-analysis that adhered to high-quality contemporary 
standards with the primary purpose of identifying what patient clinical and AET characteristics are 
associated with the greatest antihypertensive therapeutic BP benefit. 
Methods 
This study fully satisfies the criteria implied by the PRISMA Statement (Preferred Reporting 
Items for Systematic Review and Meta-Analyses) [18, 19] and AMSTAR Methodological Quality 
Scale (Assessment of Multiple SysTemAtic Reviews) [13, 20]. 
Inclusion Criteria 
 Included reports satisfied four a priori inclusion criteria: (1) involved adult participants ≥19 
yr [21-23]; (2) followed a controlled study design comparing AET to a non-exercise, non-diet control 
or comparison group; (3) reported pre-and post-intervention BP for the AET and the control/ 
comparison groups; and (4) reported the FIT of the AET intervention. Trials were excluded if they 
involved populations with diseases unrelated to CVD (i.e., cancer survivors, substance abusers, 
human immunodeficiency virus, or AIDS) or if they involved participants using weight loss drugs, 
diet therapy, or diet modifications. 
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Search Strategy 
 Aided by a medical librarian at the University of Connecticut (JL), we systematically 
searched several electronic interfaces from their inception until January 31, 2014 using a Boolean 
search strategy. Potential qualifying reports were retrieved from the following electronic databases: 
Cumulative Index to Nursing and Allied Health Literature, PubMed (including Medline), Scopus 
(including EMBASE), SportDiscus, and Web of Science (see Appendix 1 for the complete search 
strategy). The reference lists of included studies and relevant meta-analyses and reviews were also 
manually searched for additional reports. After retrieving all potentially qualifying reports, duplicate 
records were removed, and three investigators (HVM, TUG, LML) screened the sample for inclusion 
with duplication of effort.  
Approximately 2,000 potentially relevant reports were reviewed for eligibility. Of these, we 
identified 84 controlled trials that satisfied the inclusion criteria (See Appendix 2 for the reference 
list of included studies). Six trials compared the antihypertensive effects among men versus women 
[24, 25], pre- versus post-menopausal women [26], and samples with normal BP versus 
prehypertension [27] and hypertension [28, 29], yielding 90 independent AET interventions. Eleven 
trials compared >1 AET interventions to a single control group (i.e., non-independent comparisons) 
that included: lower versus higher AET intensity [30-32], frequency (days∙week-1) [33] or duration 
(min∙session-1) [34]; arm versus leg cycle ergometer [35], walking versus fitness [36], and group 
versus home-based AET performed at various intensities [25], yielding 105 total AET interventions 
(Figure 1 shows the systematic search and selection process for included AET trials).  
Data Extraction and Coded Variables 
 All coded variables were extracted using a standardized coding form and coder manual that 
was previously developed by a team of experts (LSP, BTJ, TBHM) and pilot tested. Two trained 
coders (HVM, TUG) independently extracted and entered the study information with high reliability 
across all dimensions (mean Cohen’s κ=0.82 for categorical variables [37]; mean Pearson’s r=0.90 
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for continuous variables); all disagreements were resolved by discussion. Coded variables included: 
(1) study characteristics (e.g., publication year, study location or region, primary study outcome); (2) 
experimental study design (e.g., single versus multiple AET interventions, between or within-group 
design, level of supervision); (3) sample clinical characteristics (e.g., baseline BP, age, race/ethnicity, 
sex/gender, BP medication use); and (4) features of the AET intervention including the FIT.  
 Included trials rarely disclosed the race/ethnicity of their study participants (only 18% did) 
[25, 34, 38-50]. When unreported, we estimated race/ethnicity based on the study location [51]. 
Samples were considered “White” when the study was conducted in North America, Europe  and 
Australia; “Asian” when conducted in Asian countries; “Hispanic and/or Latino” when conducted in 
South America; and “Black” when conducted in African countries.  
Methodological Study Quality Assessment  
Included trials were assessed for methodological study quality using a modified version of 
the Downs and Black Checklist [52, 53] (see Appendix 3 for the augmented checklist). This 
instrument [54] is well validated in the health science literature and has been shown to be valid and 
reliable in assessing RCTs and non-RCTs. The Downs and Black Checklist [54] addresses five 
subscales of methodological quality: (1) reporting, (2) external validity, (3) bias, (4) confounding, 
and (5) power, making it one of the most comprehensive extant instruments to evaluate study quality 
[55]. Methodological study quality score was gauged as the percentage of items satisfied out of a 
possible 29-point total. A similar approach was used to evaluate each study quality subscale, which 
provided a summary of the methodological strengths and weaknesses for each study. Consistent with 
other reviews [52, 53], ranges in overall methodological study quality scores were grouped into three 
quality levels: low (≤14 points, <50%), moderate (>14 to 23 points, 50-79%), and high (≥24 points, 
≥80%). In addition to quantifying the overall quality of the AET literature, we examined how overall 
study quality (or individual quality items) influenced the BP response to AET independently or 
interactively [56] with other moderators. 
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Study Outcomes, Effect Size Calculation, and Moderator Analyses 
The standardized mean difference effect size (d) was used to quantify the effectiveness of 
AET as antihypertensive therapy, defined as the magnitude of change in resting SBP and DBP post- 
versus pre-intervention, correcting for small sample size bias and baseline differences [57, 58]. 
Whenever possible, multiple comparisons were disaggregated for trials with more than one AET and 
control intervention groups [24-29] and analyzed as individual studies [59] (i.e., independent 
comparisons) (see Appendix 4.1 for effect size estimations). However, several trials compared two 
[30, 31, 34-36, 45, 60, 61] and three [25, 32] AET interventions to a single control group (i.e., non-
independent comparisons), to control for the dependency among our effect sizes (i.e., multiple AET 
interventions compared to a single control [62]), we used the within-group effect size estimate for all 
moderator analyses, i.e., AET and control groups were treated as separate observations (see 
Appendix 4.2 for effect size estimations). Negative d values indicated greater BP reductions were 
observed at post- compared to pre-intervention; the magnitude of the mean difference can be 
interpreted as -0.20, -0.50, and -0.80 for small, medium and large reductions in resting BP [63]. Last, 
we provided the equivalent BP change in mmHg as a supplement to the observed d in order to 
enhance the clinical relevance of our findings (see Appendices 4.3 and 4.4 for the methods used to 
calculate the raw metric in mmHg).  
We used Stata 13.1 (StataCorp, College Station, TX) [64] with macros for meta-analysis [59] 
to perform all statistical analyses, incorporating random-effects assumptions. We visually examined 
funnel plots for any asymmetries in the effect size distribution to identify potential publication or 
other reporting biases [65], in addition to performing statistical tests of bias using Begg [66] and 
Egger [67] methods. Publication bias was detected using Begg's (SBP: z=-3.13, p=0.002 and DBP: 
z=-3.40, p=0.001) but not Egger’s (SBP: t=-1.76, p=0.081 and DBP: t=-1.53, p=0.128) tests. After 
adjusting for suspected publication bias using the Duval and Tweedie trim and fill technique [68], 
our results remained significant and with high levels of heterogeneity for SBP (Q=358.2, p<0.001; 
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I2=66.7%, 95% CIs: 59.8%, 72.5%) and DBP (Q=297.2, p<0.001; I2=63.7%, 95% CIs: 55.4%, 
70.4%) [69, 70] (see Appendix 11, Figure S1, for the publication bias results, unadjusted and 
adjusted funnel plots via the trim and fill technique). However, it is important to note that these tests 
assume a single population of effect sizes and may inaccurately identify publication bias when 
significant heterogeneity is present [65, 71]. Moreover, asymmetries can also result from other 
biases, such as clinical heterogeneity and (poor) study quality [67, 72, 73]. 
Inconsistencies in d values were estimated with the I2 statistic and its confidence intervals 
(95% CIs) [70, 74]. I2 values range from 0% (homogeneity) to 100% (greater heterogeneity). As I2 
increases, homogeneity is less likely and heterogeneity is more likely; a CI that does not include 0% 
indicates that the hypothesis of homogeneity is rejected, and an inference of heterogeneity is merited 
[70, 75].  
Moderator analyses were used to explain variability in ds for SBP and DBP, using weighted 
regression models with maximum likelihood estimation of the random-effects weights, the inverse of 
the variance for each d. Continuous moderators were mean centered and categorical variables were 
contrast coded before generating interaction terms or examining multiple moderators simultaneously 
[56, 76]. Significant moderators identified with bivariate meta-regression analyses were combined in 
multiple moderator models for SBP and DBP and examined simultaneously to explain unique study 
variance. In each multiple moderator model, the moving constant technique [76] was used to estimate 
the magnitude of weighted mean effect sizes ( ) and their CIs at different levels of interest for 
individual moderators that represented a range of observations, including minimum and maximum 
values while statistically controlling for the presence of moderators. For both SBP and DBP, an 
additive model was generated from the final model that represented the greatest potential 
antihypertensive benefit that could be achieved with AET. Individual moderators and interaction 
terms were evaluated simultaneously at the level that conferred the greatest BP benefit (i.e., greatest 
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BP reductions), which in turn, demonstrated the combination of patient and AET characteristics that 
elicited optimal antihypertensive therapy. Finally, the proportion of between-study variance 
explained by the model (i.e., Multiple R) and the residual unexplained variance (i.e., I2 Residual) are 
provided (see Model Summary for Tables 2 and 3). Summary statistics are presented as Mean ± 
standard deviation (M ± SD) unless otherwise stated. Two-sided statistical significance was p<0.05. 
Results 
Study Characteristics  
AET interventions were published between 1976 and 2013 (2000±9 yr), and conducted in 
North America (51.4%, k=54), Europe (29.5%, k=31), Asia (9.5%, k=10), Africa (3.8%, k=4), 
Australia (2.9%, k=3), and South America (2.9%, k=3). Among the trials that reported sex/gender 
(three trials did not), 16 and 31 trials involved all women (18.4%) or all men (35.6%), respectively; 
the remaining trials involved samples of mixed sex/gender (46.0%, k=40). The majority of AET 
interventions were RCTs (80%, k=84) and received financial support from at least one source 
(73.3%, k=77), yet less than half examined BP as a primary study outcome (46.7%, k=49). Most 
RCTs (84.5%) used a parallel (i.e., between-subject) study design (k=71), six interventions [30, 38, 
77-79] used a within-subject, cross-over design, and small proportion of RCTs involved a “placebo” 
comparison group instead of a non-exercise or ‘wait-listed’ control. In total, 10 AET trials used 
“placebo” or “active control” that included: stretching/flexibility exercises 3 days·wk-1  [47, 80-83], 
low intensity exercise [29, 84] or yoga [85] 2-3 days·wk-1, weekly health education lectures [86], or a 
once-daily supplement (i.e., sugar pill) [87].  
[INSERT FIGURE 1] 
 Included interventions achieved “moderate” or “fair” quality on average (64.5% of items 
satisfied) [52, 53], although methodological study quality scores varied widely (41.4-86.2%). 
(Appendix 5 summarizes the overall methodological study quality for the AET sample and how well 
AET interventions satisfied individual quality items). Trials were most likely to satisfy the reporting 
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(77.5%±13.4%), internal validity-bias (70.0%±9.6%), and internal validity-confounding 
(62.6%±21.0%) quality subscales, but were least likely to satisfy external validity (49.6%±40.7) and 
power (1.7%±11.7%). None of the individual quality subscales emerged as significant moderators of 
the BP response to AET. Finally, only two trials satisfied ≥80% of the Downs and Black study 
quality checklist items (83.6%±2.8%) [38, 77]. (Appendix 6 in describes the overall and itemized 
methodological study quality for each of the included AET trials). 
Sample Characteristics 
Baseline sample characteristics were similar between the AET (n=2,200) and non-exercise 
control (n=1,434) groups (p>0.05). Overall, participants (n=3,634) were sedentary (97%), middle-
aged (47.9±12.9 yr), overweight (27.6±3.3 kg·m-2) adults with prehypertension (SBP/DBP: 
130.8±12.7/ 81.6±9.0 mmHg). The included interventions had mostly White (80%, k=72) samples 
(n=2,995), with 20% comprising a “non-White” sample: 11% (k=10) Asian (n=391) [41, 50, 78, 88-
94], 6% (k=5) African American (n=169) [45, 47, 49, 95, 96], and 3% (k=3) Hispanic/Latino (n=79) 
[80-82]. Approximately 13% (n=472) of the AET sample was on antihypertensive medication, but 
nearly half of AET trials failed to disclose BP medication use (58% did). Almost all of the AET 
interventions (88%, k=92) assessed physical fitness before and after AET, of which ~69% (k=73) did 
so via maximal or peak oxygen consumption expressed relative to body weight (58%, k=61) 
(ml∙kg∙min-1) or in absolute units (11%, k=12). Table 1 provides additional details regarding the 
different assessment techniques used to quantity fitness (see Table 1 footnote). To accommodate 
various physical fitness measurements, we examined the percent change in fitness after versus before 
AET (% change=[Fitness
Post─Pre FitnessPre⁄ ]×100%). Collectively, AET and control samples had 
poor physical fitness levels at baseline (29.0±8.1 ml∙kg∙min-1) [97]; non-White (22.7±5.0 
ml∙kg∙min-1) were lower than White samples (29.7±7.7 ml∙kg∙min-1) (p<0.001). Overall, AET 
significantly improved physical fitness compared to baseline values (~17%); fitness gains were larger 
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among non-White (19.5%±12.4%) than White samples (16.2%±14.8%) (p<0.001). In addition to 
improved physical fitness, the AET group reduced body weight, body mass index and body fat 
percent compared to baseline values (ps<0.001); the percent change from baseline was greater 
following AET versus control for body weight (-1.4%, p<0.01), body fat percent (-3.4%, p<0.01), 
and body mass index (-1.3%, p=0.05) (see Appendix 7 for a summary of select characteristics 
evaluated post- versus pre-intervention for AET and control groups).  
[INSERT TABLE 1 HERE] 
Aerobic Exercise Training Intervention Characteristics  
AET was performed at moderate-to-vigorous intensity (5.9±1.7 metabolic equivalents 
[MET]) for 44.4±23.7 min∙session-1, 3.5±1.1 days∙week-1 for 18.3±16.6 weeks. Most AET programs 
involved walking (26%), cycling (24%), or combinations of walking with cycling, jogging or running 
(23%). (See Appendix 8 for a general description of the AET and control intervention 
characteristics). Overall, AET programs were within the recommended AET volume range of ≥500‒
1,000 MET∙min∙week-1 (~850 MET∙min∙week-1) [97], with no difference in the exercise volume 
performed among White (856.5±411.7 MET∙min∙week-1) and non-White samples (827.8±300.5 
MET∙min∙week-1) (p=0.780). Direct supervision was reported in 52% of the AET interventions 
(k=55); 14% of interventions used a combination of supervised and unsupervised sessions (k=15), 
and 18% of interventions were not supervised (k=19). Finally, samples demonstrated high adherence 
to AET completing ~87% of all training sessions, but only 64% reported this detail (Appendix 8).   
Resting Blood Pressure Assessment 
Overall, included AET trials failed to disclose important details related to the resting BP 
assessment. The majority of AET interventions assessed BP manually (53%) or with an automated 
monitor (21%) while participants were in a seated (68%) or supine (32%) position, yet one-fourth of 
trials did not report these details (See Appendix 9 for the general description of the resting BP 
assessment details). A small subset of AET interventions (k=9) assessed ambulatory BP in addition 
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to causal/clinic BP [29, 30, 39, 78, 82, 89, 98, 99], but less than half monitored BP for 24 hours [29, 
82, 89]. AET interventions were least likely to disclose the timing of pre-and post-BP assessments: 
Only half (52%) reported the duration (minutes) of quiet rest preceding baseline BP assessment, and 
even fewer reported (20%) the duration (hours) between the last exercise bout and the final post-
intervention BP measurement (Appendix 9).  
The Antihypertensive Effects of Aerobic Exercise Training  
On average, small to moderate reductions in SBP (d+=-0.37; 95% CI: -0.48, -0.27; -3.5 
mmHg) and DBP (d+=-0.35; 95% CI: -0.45, -0.24; -2.7 mmHg) were observed following AET 
relative to control, whereas moderate to large reductions in SBP (d+=-0.45; 95% CI: -0.53, -0.37; -5.9 
mmHg) and DBP (d+=-0.41; 95% CI: -0.49, -0.33; -3.7 mmHg) were observed after versus before 
AET only (i.e., within-group weighted mean effect size estimates). Collectively, these effect size 
estimates lacked homogeneity. Appendix 10 provides the weighted mean effect sizes and tests for 
homogeneity (i.e., Cochran Q [100] and I2 [70, 75] statistics) for SBP and DBP. (See Appendix 12, 
Figure S2, for the contour-enhanced funnel plots, i.e., confunnels, for the visual representation of the 
effect size distribution for SBP and DBP). 
Moderator Analyses  
Bivariate meta-regression analyses revealed significant moderators for SBP and DBP related 
to sample, AET, and methodological quality characteristics. When combined in a multiple moderator 
models, significant bivariate models explained between ~48% and 90% of the observed 
heterogeneity in the BP response to AET (see Tables 2 and 3).  
Five moderators explained unique variance relating to the effectiveness of AET to reduce 
SBP when entered in a multiple regression model, accounting for ~92% of the between-study 
variance (see Table 2). Among the AET groups, SBP reductions were greater among samples with 
higher resting SBP (p=0.033), which occurred in a dose response fashion: -7.2 mmHg for 
 30 
 
hypertension, -5.0 mmHg for prehypertension, and -3.3 mmHg for normal SBP (ps<0.05). SBP was 
also reduced to greater levels among non-White (-4.1 mmHg) than White samples (-2.2 mmHg) 
(p=0.044). Furthermore, SBP reductions occurred in a dose-response pattern as a direct function of 
physical fitness gains (p=0.026): -8.4 mmHg for large (>25%‒~50%), -5.0 mmHg for moderate 
(~25%), and -2.4 mmHg for small (5%) gains (ps<0.05). The greatest SBP reductions occurred 
among samples with hypertension that achieved the largest fitness gains (-9.4 mmHg, 95% 
CI: -12.0, -6.8), an effect that was significantly greater among non-White (-12.0 mmHg) than White 
samples (-6.8 mmHg) (See Table 2, Additive Model).  
[INSERT TABLE 2 HERE] 
Three moderators explained unique variance relating to the effectiveness of AET to reduce 
DBP when entered in a multiple regression model, accounting for ~48% of the between-study 
variance (see Table 3). Among the AET groups, DBP reductions were greater among samples with 
higher resting DBP (p=0.019), which occurred in a dose response fashion: -6.1 mmHg for 
hypertension, -4.3 mmHg for prehypertension, and 1.1 mmHg for normal DBP (ps<0.05). DBP was 
also reduced to a greater levels among non-White (-3.0 mmHg) than White samples (-0.4 mmHg) 
(p=0.004). The greatest DBP reductions occurred among samples with hypertension that performed 
high volumes of AET (~1200 MET·min·week-1) (-9.3 mmHg, 95% CI: -11.9, -6.7), an effect that 
was significantly greater among non-White (-12.2 mmHg) than White samples (-6.3 mmHg) (See 
Table 3, Additive Model). 
[INSERT TABLE 3 HERE] 
Discussion 
The primary aim of our meta-analysis was to identify what patient and AET characteristics 
associated with the greatest antihypertensive therapeutic BP benefits. Consistent with prior meta-
analyses [14, 15, 101-104], we found that AET on average reduced BP ~3-4 mmHg compared to 
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control (ps<0.001). We also found the BP reductions following AET occurred in dose response 
fashion such that greater BP reductions occurred among samples with hypertension (~7/6 mmHg) 
followed by prehypertension (~5/4 mmHg), and normal BP (~3/1 mmHg) (ps≤0.033), which is 
consistent with a small subset of previously published meta-analyses [15, 103, 105, 106]. However, 
our moderator analyses revealed important, new findings that merit further comment.  
Our meta-analysis is the first to find greater BP reductions among samples with hypertension 
that achieved large fitness gains and performed high volumes of AET, an effect that was more 
pronounced among non-White (~12 mmHg) than White (~6-7 mmHg) samples. Our findings indicate 
that non-White samples, notably African American (i.e., non- Hispanic Blacks), Asian, and 
Hispanic/Latino populations, may benefit the most from the antihypertensive therapeutic benefit of 
AET. This finding is important because these patient populations tend to be at disproportionate risk 
of the sequela from CVD and other hypertension-related diseases and health conditions [1, 107-109]. 
Clearly, there is a need for RCTs that examine how different doses of AET influence the BP response 
to exercise among patient populations at disproportionate risk of CVD. Thus, more precise exercise 
prescriptions can be applied to maximize the effectiveness of AET as antihypertensive therapy for 
populations in most need of these benefits [8]. 
Surprisingly, there is little prior meta-analytic evidence to support that patient and exercise 
characteristics influence the BP response to AET [11]. Therefore, the present exercise 
recommendations for hypertension of 30-60 min∙day-1 of moderate intensity aerobic exercise on most 
days of the week [2-5, 7] are based primarily upon findings from studies of White, middle aged men 
and women adults with normal BP to stage-1 hypertension [2, 11]. Yet, ~20-25% of individuals do 
not lower their BP by following these recommendations [110, 111], and for the majority that do, the 
resultant BP reductions following AET vary considerably (1-9 mmHg) [8]. Accordingly, our meta-
analysis that adhered to high-quality methodological, contemporary standards provides insight into 
possible reasons for this variability, revealing that AET programs that produced large gains in 
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physical fitness and consisted of high exercise volume were the most effective antihypertensive 
lifestyle therapy, and the magnitude of the therapeutic BP benefit differed by race/ethnicity. How 
these new findings will translate into more precise exercise prescriptions among patient populations 
of differing race/ethnicity merits further investigation because the estimates produced with our 
additive models indicated that certain people can lower their BP following AET to similar or even 
greater magnitude than those reported with antihypertensive medications[112, 113].  
To the best of our knowledge, only one other meta-analysis [51] has investigated the 
potential impact of race/ethnicity on the BP response to AET, while two meta-analyses found that 
AET duration (min·session-1) [16, 17], intensity [15] and volume (min·week-1) [15] moderated the 
magnitude of BP reductions following AET. Reasons for our ability to better capture moderator 
patterns than prior meta-analyses are not completely clear but may reside in the fact we: (1) adhered 
to high quality contemporary, methodological standards [18, 19]; (2) evaluated and quantitatively 
incorporated the methodological quality of included AET trial into our analyses [11, 13] under the 
assumption that clearer moderation patterns and dose-response functions should be more visible 
when methodological deficits across studies are controlled [56]; and (3) applied more sophisticated 
approaches, i.e., multiple moderator models [114, 115] and the moving constant technique [76] to 
conventional meta-analytic methods (i.e., meta-regression) versus limited subgroup analysis [116, 
117]. These techniques, supplemented by our large number of included AET trials (one of the largest 
meta-analytic samples to date), enabled us to estimate the influence of individual moderators while 
statistically controlling for the presence of others in the model, and to identify novel race/ethnic-
dependent moderation patterns by generating theoretically-driven interaction terms that provided 
greater clinical translation of our findings.  
We, along with prior meta-analyses [8, 11, 17], have found this literature to be of “fair to 
moderate” methodological quality [52, 53]. In the absence of a higher quality literature, there is the 
potential risk of bias or other threats to the validity of our findings. Therefore, it is also noteworthy to 
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mention that in addition to study quality, we also examined other sources of potential bias related to 
the Downs and Black quality subscales, whether trials had BP-focused outcomes, and if our results 
differed based on the publication year, type of trial (i.e., RCT versus non-RCT), or number of 
funding sources. We then statistically examined whether these potential biases modulated the BP 
response to AET; even when these features were non-significant in bivariate meta-regression models, 
we incorporated them (when possible) to control for confounding or suppression effects that could 
arise from lower-quality trials [11, 56]. We found that higher study quality was associated with trials 
that were: published more recently (r=0.15, p=0.033), were RCTs (versus non-RCTs) (r=0.36, 
p<0.001), adequately powered to detect BP outcomes (Downs and Black Checklist Item 28) (r=0.26, 
p=0.087), and received greater amounts of funding support (r=0.12, p=0.096). Interestingly, trials 
that received greater funding support were also adequately powered (r=0.67, p<0.001) and tended to 
follow standard protocols/established guidelines when measuring BP (i.e., American Heart 
Association Council on High BP Research Part 1: Recommendations for BP measurement in Humans 
[118]) (r=0.12, p=0.099). Not surprisingly, trials that used standard protocols/established guidelines 
for BP assessment had BP-focused primary outcomes (r=0.22, p=0.002) and reported more reliable 
and accurate BP assessment methods (Downs and Black Checklist Item 21) (r=0.19, p=0.006). By 
examining the potential bias from several sources and incorporating them into our multiple 
moderator models (i.e., study quality, trial type, funding support) we can be more confident in our 
study results despite the number of methodological deficits and inconsistencies we have documented 
in this literature. 
 Our meta-analysis also identified patient profiles that may benefit the most from AET as 
antihypertensive therapy. In agreement with Whelton et al. [51] we found that greater BP reductions 
occurred among African American/Hispanic (~10/5 mmHg; k=9) and Asian (~9/6 mmHg; k=10) 
compared to White (~5/3 mmHg; k=86) samples (ps<0.034). We also found that the greatest BP 
reductions occurred among samples with hypertension that achieved the largest gains in physical 
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fitness, an effect that was more pronounced among non-White (~12 mmHg) than White (~7 mmHg) 
samples.  
Although we are not the first to report that the magnitude of BP reductions were directly 
related to improvements in fitness [101, 103, 104, 119], we are the first to document its interaction 
with race/ethnicity. Differences in cardiorespiratory fitness levels have been documented across 
racial/ethnic groups, in particular that African American [120-122] and South Asian [123, 124] 
populations have lower fitness levels compared to Whites. In support of these reports, we found that 
cardiorespiratory fitness before AET was lower among non-White than White samples (22.8 versus 
29.5 ml·kg·min-1, p=0.006). The exact mechanisms accounting for racial/ethnic differences in fitness 
levels are not fully understood, but may be related to these populations simply being more physically 
inactive [120-122, 125-127], in addition to greater vascular dysfunction [109, 120, 128, 129] related 
to elevated levels of inflammatory [130], oxidative stress and vasoconstrictive factors [128, 131]. 
AET has been shown to improve endothelial function and reverse vascular damage through repeated, 
chronic bouts of increased shear stress and by modifying other CVD risk factors [132-134], but these 
improvements are largely dependent on the level of dysfunction prior to AET [129, 132, 133, 135]. 
Interestingly, we observed greater reductions in pulse pressure, an indicator of vascular health, after 
versus before AET among non-White (-7.9%) versus White (-3.4%) samples (p<0.001). Changes in 
pulse pressure were also moderately correlated with baseline fitness (r=0.27, p=0.006), such that 
greater reductions were observed among those with low physical fitness levels (i.e., non-White 
samples). 
We also found that higher volumes of AET (~1200 MET·min·week-1) elicited the greatest BP 
benefit among adults with hypertension, ranging from ~6-12 mmHg among White and non-White 
samples, respectively. Cornelissen and Smart [15] recently reported that AET lasting 30-45 
min·session-1, performed at moderate-to-vigorous than low intensity, and lower exercise volumes 
(<210 versus >210 min∙week-1) were most effective at reducing BP. Unfortunately, the authors were 
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unable to comment on how these FIT characteristics may interact with each, or with patient clinical 
characteristics, due to the limitations of subgroup analysis. Our meta-analysis did not bear the same 
limitations. When we examined the FIT components and their interaction term (i.e., exercise 
volume=Frequency × Intensity × Time) simultaneously, their individual effects were no longer 
significant. Our findings support the current exercise volume recommendations for healthy adults 
(500-≥1000 MET·min·week-1), except that higher volumes of exercise appear more efficacious 
among non-White samples as antihypertensive lifestyle therapy. It is important to note that in our 
meta-analysis high volumes of exercise were achieved with more rigorous intensity AET (~8 MET) 
performed on 3-5 days·week-1 for 30-40 min·session-1, rather than combinations of AET consisting 
of lower intensity, high frequency (>5 days·week-1) and longer duration (>40 min·session-1).   
Despite the significant volume of exercise and hypertension literature, to date meta-analyses 
have contributed little to our understanding of what patient characteristics and AET ‘dose’ confers 
the greatest therapeutic BP benefit. In agreement with the current exercise recommendations for 
hypertension, we found that 18 weeks of moderate-to-vigorous AET performed 3-4 days·week-1 for 
~40 min·session-1 reduced resting BP ~6-7 mmHg among adults with hypertension (Table S6). Yet, 
we observed even greater reductions among samples that achieved large gains in physical fitness and 
performed higher volumes of AET, an effect that was greatest among non-White samples. 
Nonetheless, ~80% of our sample was considered White, AET interventions used various methods to 
assess physical fitness (only ~58% reported VO2peak), and features of the AET intervention were 
inconsistently reported (i.e., AET intensity, level of supervision, adherence, etc.) so that the optimal 
FIT AET prescription for hypertension and for what populations it may work best as antihypertensive 
therapy has yet to be fully elucidated.  
Even though we examined several sources for potential biases, of which some addressed the 
validity of the BP assessment methods used, it important to reinforce the poor reporting of these 
variables in the existing literature. Several reviews [2, 8, 11, 111] have commented on how the level 
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of reporting and quality of BP assessment procedures may contribute to the discrepancies observed 
across studies in the magnitude of the BP reductions following AET (i.e., unaccounted sources of 
heterogeneity). Yet, 38% of AET interventions failed to disclose any BP assessment procedures, 
while ~20-30% of AET trials failed to report specific details that included: the type of BP monitor or 
assessment tool (76% did), the body position during the BP measurement (72% did), and the timing 
of BP measurements at baseline (61% did) and post-intervention (17% did). At this time, it is unclear 
how the poor reporting and variability in these parameters influenced our results. 
In summary, our meta-analysis that adhered to high-quality methodological, contemporary 
standards confirmed that AET is effective antihypertensive therapy for adults with hypertension. 
Furthermore, we revealed that AET programs that produced large fitness gains and consisted of high 
exercise volume maximized the effectiveness of AET as antihypertensive therapy, most notably for 
non-White samples. These results indicate that the present exercise recommendations for 
hypertension should be revisited to include more precise exercise prescriptions for patient 
populations of differing race/ethnicity who are at disproportionate CVD risk. Our findings indicate a 
compelling need for additional RCTs to investigate what combinations of patient and AET 
characteristics elicit optimal antihypertensive lifestyle benefit.  
 
Acknowledgements 
We thank Lauren M. Lamberti for her assistance in screening potentially relevant reports for 
inclusion.   
Conflicts of Interest 
Supported by the University of Connecticut Center for Health, Intervention, and Prevention.  
 
  
 37 
 
References  
[1] Mozaffarian D, Benjamin EJ, Go AS, et al. (2015) Heart disease and stroke statistics-2015 
update: a report from the american heart association. Circulation 131:e29-e322  
[2] Pescatello LS, Franklin BA, Fagard R, et al. (2004) American College of Sports Medicine 
position stand: Exercise and hypertension. Med Sci Sports Exerc 36:533-553  
[3] Brook RD, Appel LJ, Rubenfire M, et al. (2013) Beyond medications and diet: Alternative 
approaches to lowering blood pressure: A scientific statement from the American heart association. 
Hypertension 61:1360-1383  
[4] Dasgupta K, Quinn RR, Zarnke KB, et al. (2014) The 2014 Canadian hypertension education 
program recommendations for blood pressure measurement, diagnosis, assessment of risk, 
prevention, and treatment of hypertension. Can J Cardiol 30:485-501  
[5] Eckel RH, Jakicic JM, Ard JD, et al. (2014) 2013 AHA/ACC guideline on lifestyle management 
to reduce cardiovascular risk: A report of the American college of cardiology/American heart 
association task force on practice guidelines. J Am Coll Cardiol 63:2960-2984  
[6] James PA, Oparil S, Carter BL, et al. (2014) 2014 Evidence-based guideline for the management 
of high blood pressure in adults: Report from the panel members appointed to the eighth joint 
national committee (JNC 8). JAMA 311:507-520  
[7] Mancia G, Fagard R, Narkiewicz K, et al. (2014) 2013 ESH/ESC practice guidelines for the 
management of arterial hypertension. Blood Press 23:3-16  
[8] Pescatello LS, MacDonald HV, Ash GI, et al. (2015) Assessing the existing professional exercise 
recommendations for hypertension: A review and recommendations for future research priorities. 
Mayo Clin Proc 90:801-812  
[9] Bouchard C, Blair SN, Church TS, et al. (2012) Adverse metabolic response to regular exercise: 
is it a rare or common occurrence? PLoS One 7:e37887  
[10] Hagberg JM, Brown MD (1995) Does exercise training play a role in the treatment of essential 
hypertension? J Cardiovasc Risk 2:296-302  
[11] Johnson BT, MacDonald HV, Bruneau MLJ, et al. (2014) Methodological quality of meta-
analyses on the blood pressure response to exercise: A review. J Hypertens 32:706-723  
[12] Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items 
for systematic reviews and meta-analyses: the PRISMA statement. J Clin Epidemiol 62:1006-1012  
[13] Shea BJ, Hamel C, Wells GA, et al. (2009) AMSTAR is a reliable and valid measurement tool 
to assess the methodological quality of systematic reviews. J Clin Epidemiol 62:1013-1020  
[14] Whelton SP, Chin A, Xin X, He J (2002) Effect of aerobic exercise on blood pressure: a meta-
analysis of randomized, controlled trials. Ann Intern Med 136:493-503  
 38 
 
[15] Cornelissen VA, Smart NA (2013) Exercise training for blood pressure: a systematic review and 
meta-analysis. J Am Heart Assoc 2:e004473  
[16] Hayashino Y, Jackson JL, Fukumori N, Nakamura F, Fukuhara S (2012) Effects of supervised 
exercise on lipid profiles and blood pressure control in people with type 2 diabetes mellitus: a meta-
analysis of randomized controlled trials. Diabetes Res Clin Pract 98:349-360  
[17] Cornelissen VA, Smart NA (2013) Exercise training for blood pressure: A systematic review 
and meta-analysis. J Am Heart Assoc 2:e004473  
[18] Moher D, Shamseer L, Clarke M, et al. (2015) Preferred reporting items for systematic review 
and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev 4:1-4053-4-1  
[19] Shamseer L, Moher D, Clarke M, et al. (2015) Preferred reporting items for systematic review 
and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 349:g7647  
[20] Shea BJ, Grimshaw JM, Wells GA, et al. (2007) Development of AMSTAR: a measurement 
tool to assess the methodological quality of systematic reviews. BMC Med Res Methodol 7:10  
[21] Overweight and Obesity: Childhood Obesity Facts. (2014) Available from: 
http://www.cdc.gov/obesity/data/childhood.html, accessed March 1, 2015 2015  
[22] Kuczmarski RJ, Ogden CL, Guo SS, et al. (2002) 2000 CDC Growth Charts for the United 
States: methods and development. Vital Health Stat 11 (246):1-190  
[23] Ogden CL, Flegal KM (2010) Changes in terminology for childhood overweight and obesity. 
Natl Health Stat Report (25):1-5  
[24] Albright CL, King AC, Barr Taylor C, Haskell WL (1992) Effect of a six-month aerobic 
exercise training program on cardiovascular responsivity in healthy middle-aged adults. J Psychosom 
Res 36:25-36  
[25] King AC, Haskell WL, Taylor CB, Kraemer HC, DeBusk RF (1991) Group- vs home-based 
exercise training in healthy older men and women. A community-based clinical trial. JAMA 
266:1535-1542  
[26] Myslivecek PR, Brown CA, Wolfe LA (2002) Effects of physical conditioning on cardiac 
autonomic function in healthy middle-aged women. Can J Appl Physiol 27:1-18  
[27] Kukkonen K, Rauramaa R, Voutilainen E, Lansimies E (1982) Physical training of middle-aged 
men with borderline hypertension. Ann Clin Res 14 Suppl 34:139-145  
[28] Cononie CC, Graves JE, Pollock ML, Phillips MI, Sumners C, Hagberg JM (1991) Effect of 
exercise training on blood pressure in 70- to 79-yr-old men and women. Med Sci Sports Exerc 
23:505-511  
[29] Gilders RM, Voner C, Dudley GA (1989) Endurance training and blood pressure in 
normotensive and hypertensive adults. Med Sci Sports Exerc 21:629-636  
 39 
 
[30] Marceau M, Kouame N, Lacourciere Y, Cleroux J (1993) Effects of different training intensities 
on 24-hour blood pressure in hypertensive subjects. Circulation 88:2803-2811  
[31] Braith RW, Pollock ML, Lowenthal DT, Graves JE, Limacher MC (1994) Moderate- and high-
intensity exercise lowers blood pressure in normotensive subjects 60 to 79 years of age. Am J Cardiol 
73:1124-1128  
[32] Gormley SE, Swain DP, High R, et al. (2008) Effect of intensity of aerobic training on 
VO2max. Med Sci Sports Exerc 40:1336-1343  
[33] Tully MA, Cupples ME, Hart ND, et al. (2007) Randomised controlled trial of home-based 
walking programmes at and below current recommended levels of exercise in sedentary adults. J 
Epidemiol Community Health 61:778-783  
[34] Dalleck LC, Allen BA, Hanson BA, Borresen EC, Erickson ME, De Lap SL (2009) Dose-
response relationship between moderate-intensity exercise duration and coronary heart disease risk 
factors in postmenopausal women. J Womens Health (Larchmt) 18:105-113  
[35] Thompson PD, Cullinane E, Lazarus B, Carleton RA (1981) Effect of exercise training on the 
untrained limb exercise performance of men with angina pectoris. Am J Cardiol 48:844-850  
[36] Bell GJ, Harber V, Murray T, Courneya KS, Rodgers W (2010) A comparison of fitness training 
to a pedometer-based walking program matched for total energy cost. J Phys Act Health 7:203-213  
[37] Cohen J (1968) Weighted kappa: nominal scale agreement with provision for scaled 
disagreement or partial credit. Psychol Bull 70:213-220  
[38] Bateman LA, Slentz CA, Willis LH, et al. (2011) Comparison of Aerobic Versus Resistance 
Exercise Training Effects on Metabolic Syndrome (from the Studies of a Targeted Risk Reduction 
Intervention Through Defined Exercise - STRRIDE-AT/RT). Am J Cardiol 108:838-844  
[39] Blumenthal JA, Siegel WC, Appelbaum M (1991) Failure of exercise to reduce blood pressure 
in patients with mild hypertension. Results of a randomized controlled trial. JAMA 266:2098-2104  
[40] Fritz T, Wandell P, Aberg H, Engfeldt P (2006) Walking for exercise--does three times per week 
influence risk factors in type 2 diabetes? Diabetes Res Clin Pract 71:21-27  
[41] Higashi Y, Sasaki S, Sasaki N, et al. (1999) Daily aerobic exercise improves reactive hyperemia 
in patients with essential hypertension. Hypertension 33:591-597  
[42] Hill RD, Storandt M, Malley M (1993) The impact of long-term exercise training on 
psychological function in older adults. J Gerontol 48:P12-7  
[43] Krustrup P, Nielsen JJ, Krustrup BR, et al. (2009) Recreational soccer is an effective health-
promoting activity for untrained men. Br J Sports Med 43:825-831  
 40 
 
[44] Krustrup P, Hansen PR, Randers MB, et al. (2010) Beneficial effects of recreational football on 
the cardiovascular risk profile in untrained premenopausal women. Scand J Med Sci Sports 20 Suppl 
1:40-49  
[45] Oluseye KA (1990) Cardiovascular responses to exercise in Nigerian women. J Hum Hypertens 
4:77-79  
[46] Parkkari J, Natri A, Kannus P, et al. (2000) A controlled trial of the health benefits of regular 
walking on a golf course. Am J Med 109:102-108  
[47] Potempa K, Lopez M, Braun LT, Szidon JP, Fogg L, Tincknell T (1995) Physiological 
outcomes of aerobic exercise training in hemiparetic stroke patients. Stroke 26:101-105  
[48] Sigal RJ, Kenny GP, Boule NG, et al. (2007) Effects of aerobic training, resistance training, or 
both on glycemic control in type 2 diabetes: a randomized trial. Ann Intern Med 147:357-369  
[49] Sohn AJ, Hasnain M, Sinacore JM (2007) Impact of exercise (walking) on blood pressure levels 
in African American adults with newly diagnosed hypertension. Ethn Dis 17:503-507  
[50] Tsuda K, Yoshikawa A, Kimura K, Nishio I (2003) Effects of mild aerobic physical exercise on 
membrane fluidity of erythrocytes in essential hypertension. Clin Exp Pharmacol Physiol 30:382-386  
[51] Whelton SP, Chin A, Xin X, He J (2002) Effect of aerobic exercise on blood pressure: A meta-
analysis of randomized, controlled trials. Ann Intern Med 136:493-503  
[52] Chudyk AM, Jutai JW, Petrella RJ, Speechley M (2009) Systematic review of hip fracture 
rehabilitation practices in the elderly. Arch Phys Med Rehabil 90:246-262  
[53] Samoocha D, Bruinvels DJ, Elbers NA, Anema JR, van der Beek AJ (2010) Effectiveness of 
web-based interventions on patient empowerment: a systematic review and meta-analysis. J Med 
Internet Res 12:e23  
[54] Downs SH, Black N (1998) The feasibility of creating a checklist for the assessment of the 
methodological quality both of randomised and non-randomised studies of health care interventions. 
J Epidemiol Community Health 52:377-384  
[55] Deeks JJ, Dinnes J, D'Amico R, et al. (2003) Evaluating non-randomised intervention studies. 
Health Technol Assess 7:iii-x, 1-173  
[56] Johnson BT, Low RE, MacDonald HV (2015) Panning for the gold in health research: 
Incorporating studies' methodological quality in meta-analysis. Psychol Health 30:135-152  
[57] Hedges LV, Olkin I (1985) Statistical Methods for Meta-analysis. Academic Press Inc, Orlando 
FL, USA  
[58] Becker BJ (1988) Synthesizing standardized mean-change measures. Br J Math Stat Psychol 
41:257-278  
 41 
 
[59] Lipsey M, Wilson D (2001) Practical meta-analysis. Sage, Thousand Oaks, CA  
[60] Tjonna AE, Lee SJ, Rognmo O, et al. (2008) Aerobic interval training versus continuous 
moderate exercise as a treatment for the metabolic syndrome: a pilot study. Circulation 118:346-354  
[61] Nybo L, Sundstrup E, Jakobsen MD, et al. (2010) High-intensity training versus traditional 
exercise interventions for promoting health. Med Sci Sports Exerc 42:1951-1958  
[62] Viechtbauer W (2010) Conducting meta-analyses in R with the metafor package. Journal of 
Statistical Software 36:1-48  
[63] Cohen J (1988) Statistical power analysis for the behavioral sciences. L. Erlbaum Associates, 
Hillsdale  
[64] StataCorp LP. (2013) Stata statistical software: Release 13. Version 13.1.  
[65] Sterne JAC, Egger M, Moher D, The Cochrane Bias Methods Group. (2008) Chapter 10: 
Addressing reporting biases. In: Higgins JPT, Green S (eds) Cochrane Handbook for Systematic 
Reviews of Interventions. Version 5.0.1 [updated September 2008]. The Cochrane Collaboration, 
Available from www.cochrane-handbook.org  
[66] Begg CB, Mazumdar M (1994) Operating characteristics of a rank correlation test for 
publication bias. Biometrics 50:1088-1101  
[67] Egger M, Smith G, Schneider M, Minder C (1997) Bias in meta-analysis detected by a simple, 
graphical test. BMJ 315:629-34  
[68] Duval S, Tweedie R (2000) Trim and fill: A simple funnel-plot-based method of testing and 
adjusting for publication bias in meta-analysis. Biometrics 56:455-463  
[69] Johnson BT, Huedo-Medina TB, LaCroix JM (2010) Converting Q to I2: A spreadsheet.  
[70] Huedo-Medina TB, Sanchez-Meca J, Marin-Martinez F (2006) Assessing heterogeneity in meta-
analysis: Q statistic or I2 index? Psychol Methods 11:193-206  
[71] Sterne JAC, Gavaghan D, Egger M (2000) Publication and related bias in meta-analysis: power 
of statistical tests and prevalence in the literature. J Clin Epidemiol 53:1119-1129  
[72] Sterne JAC, Egger M, Smith GD (2001) Systematic reviews in health care: Investigating and 
dealing with publication and other biases in meta-analysis. BMJ 323:101-105  
[73] Deeks JJ, Macaskill P, Irwig L (2005) The performance of tests of publication bias and other 
sample size effects in systematic reviews of diagnostic test accuracy was assessed. J Clin Epidemiol 
58:882-893  
[74] Higgins JPT, Green S (eds) (2011) Cochrane Handbook for Systematic Reviews of 
Interventions. Version 5.1.0. The Cochrane Collaboration, Available from www.cochrane-
handbook.org.  
 42 
 
[75] Higgins JPT, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-
analyses. BMJ 327:557-560  
[76] Johnson BT, Huedo-Medina TB (2011) Depicting estimates using the intercept in meta-
regression models: the moving constant technique. Research Synthesis Methods 2:204-220  
[77] Ferrier KE, Waddell TK, Gatzka CD, Cameron JD, Dart AM, Kingwell BA (2001) Aerobic 
exercise training does not modify large-artery compliance in isolated systolic hypertension. 
Hypertension 38:222-226  
[78] Miyai N, Arita M, Miyashita K, et al. (2002) Antihypertensive effects of aerobic exercise in 
middle-aged normotensive men with exaggerated blood pressure response to exercise. Hypertens Res 
25:507-514  
[79] Reid CM, Dart AM, Dewar EM, Jennings GL (1994) Interactions between the effects of 
exercise and weight loss on risk factors, cardiovascular haemodynamics and left ventricular structure 
in overweight subjects. J Hypertens 12:291-301  
[80] Jorge ML, de Oliveira VN, Resende NM, et al. (2011) The effects of aerobic, resistance, and 
combined exercise on metabolic control, inflammatory markers, adipocytokines, and muscle insulin 
signaling in patients with type 2 diabetes mellitus. Metabolism 60:1244-1252  
[81] Oliveira VNd, Bessa A, Jorge MLMP, et al. (2012) The effect of different training programs on 
antioxidant status, oxidative stress, and metabolic control in type 2 diabetes. Applied Physiology, 
Nutrition & Metabolism 37:334-344  
[82] Reboredo Mde M, Henrique DM, Faria Rde S, Chaoubah A, Bastos MG, de Paula RB (2010) 
Exercise training during hemodialysis reduces blood pressure and increases physical functioning and 
quality of life. Artif Organs 34:586-593  
[83] Steinhaus LA, Dustman RE, Ruhling RO, et al. (1990) Aerobic capacity of older adults: a 
training study. J Sports Med Phys Fitness 30:163-172  
[84] Madden KM, Lockhart C, Potter TF, Cuff D (2010) Aerobic training restores arterial baroreflex 
sensitivity in older adults with type 2 diabetes, hypertension, and hypercholesterolemia. Clin J Sport 
Med 20:312-317  
[85] Bowman AJ, Clayton RH, Murray A, Reed JW, Subhan MM, Ford GA (1997) Effects of aerobic 
exercise training and yoga on the baroreflex in healthy elderly persons. Eur J Clin Invest 27:443-449  
[86] Posner JD, Gorman KM, Windsor-Landsberg L, et al. (1992) Low to moderate intensity 
endurance training in healthy older adults: physiological responses after four months. J Am Geriatr 
Soc 40:1-7  
[87] Ho SS, Radavelli-Bagatini S, Dhaliwal SS, Hills AP, Pal S (2012) Resistance, aerobic, and 
combination training on vascular function in overweight and obese adults. J Clin Hypertens 
(Greenwich) 14:848-854  
 43 
 
[88] Wang JS, Jen CJ, Chen HI (1997) Effects of chronic exercise and deconditioning on platelet 
function in women. J Appl Physiol (1985) 83:2080-2085  
[89] Tsai JC, Yang HY, Wang WH, et al. (2004) The beneficial effect of regular endurance exercise 
training on blood pressure and quality of life in patients with hypertension. Clin Exp Hypertens 
26:255-265  
[90] Wang JS, Li YS, Chen JC, Chen YW (2005) Effects of exercise training and deconditioning on 
platelet aggregation induced by alternating shear stress in men. Arterioscler Thromb Vasc Biol 
25:454-460  
[91] Arora E, Shenoy S, Sandhu JS (2009) Effects of resistance training on metabolic profile of 
adults with type 2 diabetes. Indian J Med Res 129:515-519  
[92] Chaudhary S, Kang MK, Sandhu JS (2010) The effects of aerobic versus resistance training on 
cardiovascular fitness in obese sedentary females. Asian Journal of Sports Medicine 1:177-184  
[93] Sridhar B, Haleagrahara N, Bhat R, Kulur AB, Avabratha S, Adhikary P (2010) Increase in the 
heart rate variability with deep breathing in diabetic patients after 12-month exercise training. 
Tohoku J Exp Med 220:107-113  
[94] Tseng ML, Ho CC, Chen SC, Huang YC, Lai CH, Liaw YP (2013) A simple method for 
increasing levels of high-density lipoprotein cholesterol: A pilot study of combination aerobic- and 
resistance-exercise training. Int J Sport Nutr Exerc Metab 23:271-281  
[95] Lamina S, Okoye CG, Dagogo TT (2009) Managing erectile dysfunction in hypertension: the 
effects of a continuous training programme on biomarker of inflammation. BJU Int 103:1218-1221  
[96] Shaw BS (2010) Resting cardiovascular function improvements in adult men following 
resistance training. African Journal for Physical, Health Education, Recreation & Dance 16:402-410  
[97] American College of Sports Medicine. (2013) ACSM's guidelines for exercise testing and 
prescription. Lippincott Williams & Wilkins, Philadelphia PA, USA  
[98] Cooper AR, Moore LA, McKenna J, Riddoch CJ (2000) What is the magnitude of blood 
pressure response to a programme of moderate intensity exercise? Randomised controlled trial 
among sedentary adults with unmedicated hypertension. Br J Gen Pract 50:958-962  
[99] Van Hoof R, Hespel P, Fagard R, Lijnen P, Staessen J, Amery A (1989) Effect of endurance 
training on blood pressure at rest, during exercise and during 24 hours in sedentary men. Am J 
Cardiol 63:945-949  
[100] Cochran W (1954) The combination of estimates from different experiments. Biometrics 
10:101-129  
[101] Kelley GA, Kelley KS, Tran ZV (2001) Walking and resting blood pressure in adults: a meta-
analysis. Prev Med 33:120-127  
 44 
 
[102] Fagard RH (2001) Exercise characteristics and the blood pressure response to dynamic 
physical training. Med Sci Sports Exerc 33:S484-92; discussion S493-4  
[103] Cornelissen VA, Fagard RH (2005) Effects of endurance training on blood pressure, blood 
pressure-regulating mechanisms, and cardiovascular risk factors. Hypertension 46:667-675  
[104] Cornelissen VA, Buys R, Smart NA (2013) Endurance exercise beneficially affects ambulatory 
blood pressure: a systematic review and meta-analysis. J Hypertens 31:639-648  
[105] Kelley GA, Kelley KS (2001) Aerobic exercise and resting blood pressure in older adults: a 
meta-analytic review of randomized controlled trials. J Gerontol A Biol Sci Med Sci 56:M298-303  
[106] Kelley GA, Kelley KA, Tran ZV (2001) Aerobic exercise and resting blood pressure: a meta-
analytic review of randomized, controlled trials. Prev Cardiol 4:73-80  
[107] The Asia-Pacific perspective: Redefining obesity and its treatment. Available from: 
http://www.wpro.who.int/nutrition/documents/docs/Redefiningobesity.pdf?ua=1, accessed May 24 
2014  
[108] IDF Clinical Practice Guidelines. Available from: http://www.idf.org/, accessed July 07 2015  
[109] Flack JM, Sica DA, Bakris G, et al. (2010) Management of high blood pressure in Blacks: an 
update of the International Society on Hypertension in Blacks consensus statement. Hypertension 
56:780-800  
[110] Hagberg JM, Park JJ, Brown MD (2000) The role of exercise training in the treatment of 
hypertension: an update. Sports Med 30:193-206  
[111] Pescatello LS, Kulikowich JM (2001) The aftereffects of dynamic exercise on ambulatory 
blood pressure. Med Sci Sports Exerc 33:1855-1861  
[112] ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. (2002) 
Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme 
inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering 
Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA 288:2981-2997  
[113] Brown RE, Riddell MC, Macpherson AK, Canning KL, Kuk JL (2013) The joint association of 
physical activity, blood-pressure control, and pharmacologic treatment of hypertension for all-cause 
mortality risk. Am J Hypertens 26:1005-1010  
[114] Nakanishi Y, Toyoizumi S, Nakajima A, Hamada C (2007) Subgroup analysis in meta-
analysis: A comparison of different methods. Jpn J Pharmacoepidemiol 12:13-24  
[115] Johnson BT, Huedo-Medina TB (2013) Meta-Analytic Statistical Inferences for Continuous 
Measure Outcomes as a Function of Effect Size Metric and Other Assumptions. Available from: 
http://www.ncbi.nlm.nih.gov/books/NBK140575/  
 45 
 
[116] Aguinis H, Gottfredson RK, Wright TA (2011) Best-practice recommendations for estimating 
interaction effects using meta-analysis. J Organ Behav 32:1033-1043  
[117] Assmann SF, Pocock SJ, Enos LE, Kasten LE (2000) Subgroup analysis and other (mis)uses of 
baseline data in clinical trials. Lancet 355:1064-1069  
[118] Pickering TG, Hall JE, Appel LJ, et al. (2005) Recommendations for blood pressure 
measurement in humans and experimental animals: Part 1: Blood pressure measurement in humans: 
A statement for professionals from the Subcommittee of Professional and Public Education of the 
American Heart Association Council on High Blood Pressure Research. Hypertension 45:142-161  
[119] Fagard RH (1993) Physical fitness and blood pressure. J Hypertens Suppl 11:S47-52  
[120] Swift DL, Staiano AE, Johannsen NM, et al. (2013) Low cardiorespiratory fitness in African 
Americans: a health disparity risk factor? Sports Med 43:1301-1313  
[121] Ceaser TG, Fitzhugh EC, Thompson DL, Bassett DR,Jr (2013) Association of physical 
activity, fitness, and race: NHANES 1999-2004. Med Sci Sports Exerc 45:286-293  
[122] Howard EN, Frierson GM, Willis BL, Haskell WL, Powell-Wiley TM, Defina LF (2013) The 
impact of race and higher socioeconomic status on cardiorespiratory fitness. Med Sci Sports Exerc 
45:2286-2291  
[123] Ghouri N, Purves D, McConnachie A, Wilson J, Gill JM, Sattar N (2013) Lower 
cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia in middle-
aged South Asian compared with European men living in the UK. Diabetologia 56:2238-2249  
[124] Celis-Morales CA, Ghouri N, Bailey ME, Sattar N, Gill JM (2013) Should physical activity 
recommendations be ethnicity-specific? Evidence from a cross-sectional study of South Asian and 
European men. PLoS One 8:e82568  
[125] de Munter JS, van Valkengoed IG, Agyemang C, Kunst AE, Stronks K (2010) Large ethnic 
variations in recommended physical activity according to activity domains in amsterdam, the 
netherlands. Int J Behav Nutr Phys Act 7:85-5868-7-85  
[126] de Munter JS, Agyemang C, Brewster LM, Stronks K, van Valkengoed IG (2012) The 
association of leisure-time physical activity and active commuting with measures of socioeconomic 
position in a multiethnic population living in the Netherlands: results from the cross-sectional 
SUNSET study. BMC Public Health 12:815-2458-12-815  
[127] Lakoski SG, Kozlitina J (2014) Ethnic differences in physical activity and metabolic risk: the 
Dallas Heart Study. Med Sci Sports Exerc 46:1124-1132  
[128] Kalinowski L, Dobrucki IT, Malinski T (2004) Race-specific differences in endothelial 
function: predisposition of African Americans to vascular diseases. Circulation 109:2511-2517  
 46 
 
[129] Swift DL, Earnest CP, Blair SN, Church TS (2012) The effect of different doses of aerobic 
exercise training on endothelial function in postmenopausal women with elevated blood pressure: 
results from the DREW study. Br J Sports Med 46:753-758  
[130] LaMonte MJ, Durstine JL, Yanowitz FG, et al. (2002) Cardiorespiratory fitness and C-reactive 
protein among a tri-ethnic sample of women. Circulation 106:403-406  
[131] Campia U, Cardillo C, Panza JA (2004) Ethnic differences in the vasoconstrictor activity of 
endogenous endothelin-1 in hypertensive patients. Circulation 109:3191-3195  
[132] Green DJ, Maiorana A, O'Driscoll G, Taylor R (2004) Effect of exercise training on 
endothelium-derived nitric oxide function in humans. J Physiol 561:1-25  
[133] Moyna NM, Thompson PD (2004) The effect of physical activity on endothelial function in 
man. Acta Physiol Scand 180:113-123  
[134] Tinken TM, Thijssen DH, Black MA, Cable NT, Green DJ (2008) Time course of change in 
vasodilator function and capacity in response to exercise training in humans. J Physiol 586:5003-
5012  
[135] Lavrencic A, Salobir BG, Keber I (2000) Physical training improves flow-mediated dilation in 
patients with the polymetabolic syndrome. Arterioscler Thromb Vasc Biol 20:551-555  
[136] Davies B, Daggett A (1977) Responses of adult women to programmed exercise. Br J Sports 
Med 11:122-126  
[137] Wood RH, Reyes R, Welsch MA, et al. (2001) Concurrent cardiovascular and resistance 
training in healthy older adults. Med Sci Sports Exerc 33:1751-1758  
[138] Norris R, Carroll D, Cochrane R (1990) The effects of aerobic and anaerobic training on 
fitness, blood pressure, and psychological stress and well-being. J Psychosom Res 34:367-375  
[139] Moreau KL, Degarmo R, Langley J, et al. (2001) Increasing daily walking lowers blood 
pressure in postmenopausal women. Med Sci Sports Exerc 33:1825-1831  
[140] Swartz AM, Strath SJ, Bassett DR, et al. (2003) Increasing daily walking improves glucose 
tolerance in overweight women. Prev Med 37:356-362  
[141] Tudor-Locke C, Bell RC, Myers AM, et al. (2004) Controlled outcome evaluation of the First 
Step Program: a daily physical activity intervention for individuals with type II diabetes. Int J Obes 
Relat Metab Disord 28:113-119  
[142] Suter E, Marti B, Tschopp A, Wanner HU, Wenk C, Gutzwiller F (1990) Effects of self-
monitored jogging on physical fitness, blood pressure and serum lipids: a controlled study in 
sedentary middle-aged men. Int J Sports Med 11:425-432  
[143] Ketelhut RG, Franz IW, Scholze J (2004) Regular exercise as an effective approach in 
antihypertensive therapy. Med Sci Sports Exerc 36:4-8  
 47 
 
 
Table 1. Summary of the baseline sample characteristics for the aerobic exercise training 
(k=105) and control (k=90) groups. 
    AET (n=2,200)    Control (n=1,434) 
Characteristics  k  Mean ± sd  Range  k  Mean ± sd  Range 
Women (%)  101  41.7 ± 38.1   0.0, 100.0  84  40.5 ± 37.8  0.0, 100.0 
Age (years)  105  47.9 ± 12.8   20.1, 72.0  85  47.8 ± 13.0  21.6, 72.0 
BP Medication Use (%)   75  12.0 ± 24.7  0.0, 100.0  53  12.5 ± 22.6  0.0, 100.0 
CVD risk factors/ presence 
of disease (%) 
 101  29.6 ± 45.6  0.0, 100.0  53  12.5 ± 22.6  0.0, 100.0 
Race/Ethnicity (%) *             
White  86  81.9%  n=1,849  72  80.0%  n=1,146 
Asian  10  9.5%  n=223  10  11.1%  n=168 
African American/Black  6  5.7%  n=91  5  5.6%  n=78 
Hispanic/Latino/Caribbean  3  2.9%  n=37  3  3.3%  n=42 
Sedentary (%)  105  97.4 ± 15.2  0.0, 100.0  90  97.3 ± 15.0  0.0, 100.0 
Body Composition             
Body Weight (kg)  79  78.8 ± 10.4  53.4, 102.4  65  78.2 ± 11.4  53.3, 107.3 
Body Mass Index (kg∙m
-2
)  79  27.4 ± 3.2  21.9, 35.4  63  27.6 ± 3.5  20.3, 37.2 
Body Fat (%)  29  30.4 ± 7.4  22.0, 49.6  27  30.4 ± 7.4  22.0, 49.6 
Resting Hemodynamics             
Systolic BP (mmHg)  105  130.7 ± 12.7  101.2, 167.6  89  130.8 ± 12.7  101.2, 160.0 
Diastolic BP (mmHg)  101  81.7 ± 9.0  63.0, 102.0  85  81.5 ± 9.1  58.0, 102.0 
MAP (mmHg)  101  98.1 ± 10.0  78.3, 123.5  85  98.1 ± 9.9  74.0, 120.0 
Pulse Pressure (mmHg)  101  49.2 ± 6.9  35.0, 77.5  85  49.8 ± 7.3  35.0, 77.5 
Heart Rate (beats∙min
-1
)  12  71.1 ± 3.8  65.0, 75.0  12  71.3 ± 7.6  59.8, 84.0 
Physical Fitness †  92  87.6%    65  72.2%   
VO2max/VO2peak 
(ml∙kg∙min
-1
) 
 61  28.8 ± 7.4  14.5, 45.7  43  29.4 ± 8.2  14.3, 49.4 
VO2max (L∙min
-1
)  12  1.7 ± 1.0  0.3, 3.1  8  1.6 ± 1.0  0.3, 3.0 
 
6MWT/SWT (m)  4  583.3 ± 55.4  504.6, 631.0  3  521.5 ± 33.4  500.0, 560.0 
Note. Descriptive statistics are presented as Mean ± standard deviation (sd) unless otherwise stated; Range= 
Minimum, Maximum. k=the number of observations. Abbr. AET=Aerobic exercise training. BP=Blood 
pressure. CVD= Cardiovascular disease. MAP=Mean arterial pressure. VO2max=Maximal oxygen uptake. 
VO2peak=Peak oxygen uptake. 6MWT=Six minute walk test. SWT=Shuttle walk test. * Ethnicity/Race was 
reported in 16 interventions: White (76-100%) [25, 34, 39, 40, 42-44, 46]; African American/Black (100%) [45, 
49]; Asian (100%) [41, 50];  or mixed samples (White=50-98%, Black=17-43%, Hispanic=7% or ‘Other’=3%) 
[38, 47, 48]. † Other physical fitness assessments: Exercise/ physical work capacity (Watts) [78, 135, 136]; 
Graded exercise test (min) [137]; Timed 1.5 mile run (min) [138]; Maximal exercise capacity (Metabolic 
equivalent unit) [89]; Maximal exercise capacity (Heart rate, beats∙min-1) [92]; Walking activity (km∙day -1 [139] 
or steps∙day -1 [140, 141]); 400-m Endurance capacity test (min∙km -1) [142]; Cardiorespiratory endurance index 
step test (no units) [94]; Maximal workload (work level) [35]; Physical activity (kcal∙day -1) [98]; Rate pressure 
product [143]. 
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Abstract 
Aerobic exercise is recommended as first-line antihypertensive lifestyle therapy due to a strong body 
of evidence showing it lowers blood pressure (BP) 5-7 mmHg among adults with hypertension. Due 
to weaker evidence showing dynamic resistance training (RT) reduces BP 2-3 mmHg among adults 
with hypertension, RT is recommended as adjuvant lifestyle therapy to aerobic exercise training. Yet, 
several lines of evidence exist that suggest RT can lower BP to equal to or greater levels than aerobic 
exercise. Therefore, we meta-analyzed 64 controlled trials (71 RT interventions) to determine the 
efficacy of dynamic RT as stand-alone antihypertensive therapy. Participants (n=2,374) were White 
(56%), middle-aged (47.2±19.0 yr), overweight (26.8±3.4 kg∙m-2) adults with prehypertension 
(systolic BP [SBP]/diastolic BP [DBP]: 126.7±10.3/76.8±8.7 mmHg); with 17% on antihypertensive 
medication. Overall, moderate-intensity dynamic RT was performed 2.8±0.6 days·week-1 for 
14.4±7.9 weeks and elicited small-to-moderate reductions in SBP (d+=-0.31, 95% 
CIs: -0.43, -0.19; -3.0 mmHg) and DBP (d+=-0.30, 95% CIs: -0.38, -0.18; -2.1 mmHg) compared to 
controls (ps<0.001). Greater BP reductions occurred among samples with higher resting BP: ~6/5 
mmHg for hypertension, ~3/3 mmHg for prehypertension, and ~0/1 mmHg for normal BP 
(p=0.001/0.023 for SBP/DBP, respectively). Furthermore, BP reductions approximately double the 
magnitude of those reported following aerobic exercise training occurred among non-White samples 
with hypertension (-14.3 mmHg, 95% CIs: -19.0, -9.4/-10.3 mmHg, 95% CIs: -14.5, -6.2). Our 
results indicate that for adults with hypertension, notably non-White samples, dynamic RT may be as 
or even more effective than aerobic exercise in lowering BP. RT should be further investigated as a 
viable stand-alone therapeutic exercise option for adults with hypertension. 
 
Key words: Blood Pressure; Exercise; Hypertension; Strength Training; Systematic Review 
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Introduction 
Hypertension is the most prevalent, modifiable and costly risk factor for cardiovascular 
disease (CVD) [1]. Hypertension leads to an estimated 9.4 million annual deaths worldwide, which is 
about as many deaths that result from all infectious diseases combined [2]. Nearly ~33% (80 million) 
of US adults currently have hypertension [1]; and by 2030, this number is projected to reach 41.1% 
[1, 3]. Lifestyle-related factors are the only modifiable determinants of hypertension [3]; therefore, 
more intensive efforts should be focused on promoting these strategies to reduce the significant 
public health burden of hypertension [1]. 
Many randomized control trials (RCTs) have investigated the antihypertensive effects of 
exercise, and in turn, over 33 meta-analyses have been published to date [4, 5]. Collectively, these 
meta-analyses concluded that aerobic training lowers blood pressure (BP) 5-7 mmHg [6-8], while 
dynamic resistance training (RT) lowers BP 2-3 mmHg [6, 8-11] among adults with hypertension. 
Accordingly, 30-60 min∙day-1 of moderate-intensity aerobic exercise is recommended on most days 
of the week [6, 12-15] supplemented by moderate-intensity dynamic RT on ≥2 days∙week-1 [6, 12, 
14] to prevent, treat and control hypertension. Yet, a more critical review of this literature revealed 
considerable variability in the magnitude of the BP reductions following both aerobic exercise 
training (i.e., 1-9 mmHg) [5] and dynamic RT (i.e., 0-6 mmHg) [6, 10, 16, 17], for reasons that are 
not clear [5, 12].  
In contrast to the high-level of evidence supporting the BP-lowering effects of aerobic 
training [5], there is much weaker evidence supporting the efficacy of RT as a viable therapeutic 
option to lower BP among adults with hypertension that is primarily based on the findings of six 
meta-analyses [5, 8-11, 16, 17]. Surprisingly, these meta-analyses included mostly healthy adults 
with normal BP and prehypertension. Furthermore, none of these meta-analysis completely satisfied 
contemporary methodological study quality standards [4, 18, 19], nor were they able to identify 
important patient or RT characteristics that modulated the BP response to dynamic RT. Collectively, 
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these observations suggest that the antihypertensive effects of RT may have been underestimated, 
and they call into question the generalizability of this weak and limited literature to adults with 
hypertension [4, 5].  
Furthermore, several primary level RT studies have shown that the resultant BP reductions 
following dynamic RT may be comparable to that of aerobic training among adults with hypertension 
[20-29]. Mota and colleagues [29] found that 16 weeks of moderate-intensity dynamic RT reduced 
BP ~14/4 mmHg among 32 older women with controlled hypertension. In another study, Moraes et 
al. [30] found that 12 weeks of moderate-intensity RT reduced BP ~16/12 mmHg among 15 middle-
aged men with hypertension. Moraes et al. concluded that dynamic RT performed three days per 
week was effective as stand-alone antihypertensive therapy. A limited number of controlled trials 
have directly compared the effectiveness of aerobic training versus RT as antihypertensive therapy 
[21-23, 26, 31-34]. Yet, most of these trials found that aerobic exercise training and dynamic RT 
lowered systolic BP (SBP)/diastolic BP (DBP) to similar levels among adults with untreated (~7/6 
mmHg [22]; 14/8 mmHg [21]) and controlled (~10/3 mmHg) hypertension [23, 26]. BP reductions of 
this magnitude following RT have also been observed among young (~9-15/6-8 mmHg) [31, 32, 35] 
and middle-aged (~8-10/5-7 mmHg) [33, 34, 36] adults with prehypertension. 
Therefore, the purposes of our meta-analysis are to determine the efficacy of dynamic RT as 
stand-alone antihypertensive therapy, and identify potential moderators of the BP response to provide 
insight into the optimal dose of RT to lower BP among adults with hypertension. 
Methods 
This study fully satisfies the criteria implied by the PRISMA Statement (Preferred Reporting 
Items for Systematic Review and Meta-Analyses) [19, 37] and AMSTAR Methodological Quality 
Scale (Assessment of Multiple SysTemAtic Reviews) [18, 38]. 
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Inclusion Criteria 
 Included reports satisfied four a priori inclusion criteria: (1) involved adult participants (≥19 
yrs) [39-41]; (2) followed a controlled study design comparing dynamic RT to a non-exercise, non-
diet control or comparison group; (3) reported pre-and post-intervention BP for the RT and the 
control/comparison groups; and (4) reported the Frequency, Intensity, and Time (or FIT) of the RT 
intervention. Trials were excluded if they involved populations with diseases unrelated to CVD (i.e., 
cancer survivors, substance abusers, human immunodeficiency virus or AIDS) or if they involved 
participants using weight loss drugs, diet therapy, or diet modifications. 
Search Strategy  
 Aided by a medical librarian at the University of Connecticut (JL), we systematically 
searched several electronic interfaces from their inception until January 31, 2014 using a Boolean 
search strategy. Potential qualifying reports were retrieved from the following electronic databases: 
Cumulative Index to Nursing and Allied Health Literature, PubMed (including Medline), Scopus 
(including EMBASE), SportDiscus, and Web of Science (see Appendix 1 for the complete search 
strategy). The reference lists of included studies and relevant meta-analyses and reviews were also 
manually searched for additional reports. After retrieving all potentially qualifying reports, duplicate 
records were removed, and four investigators (HVM, TUG, KF, LML) screened the sample for 
inclusion with duplication of effort.   
We identified 64 controlled trials that satisfied the inclusion criteria (See Appendix 13 for the 
reference list of included studies). Figure 1 shows the systematic search for potential reports and 
selection process of included dynamic RT trials. Seven trials involved ≥1 RT groups comparing: 
lower versus high intensity RT [42-45], strength versus power RT [46], elastic band versus aquatic 
RT [47], and eccentric versus concentric RT [48], yielding 71 total interventions. 
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Data Extraction and Coded Variables  
All coded variables were extracted using a standardized coding form and coder manual that 
was previously developed by a team of experts (LSP, BTJ, TBHM) and pilot tested. Two trained 
coders (HVM, KF) independently extracted and entered the study information with high reliability 
across all dimensions (mean Cohen’s κ=0.86 for categorical variables [49]; mean Pearson’s r=0.94 
for continuous variables); all disagreements were resolved by discussion. Coded variables included: 
(1) study characteristics (e.g., publication year, study location or region, primary study outcome); (2) 
experimental study design (e.g., single versus multiple RT interventions, between or within-group 
design, level of supervision); (3) sample clinical characteristics (e.g., baseline BP, age, race/ethnicity, 
sex/gender, BP medication use); and (4) features of the dynamic RT intervention including the FIT 
characteristics.  
Included trials rarely disclosed the race/ethnicity of their study participants (only 14% did) 
[22, 23, 42, 50-55]. When unreported, we estimated race/ethnicity based on the study location [56]. 
Samples were considered “White” when the study was conducted in North America, Europe  and 
Australia; “Asian” when conducted in Asian countries; “Hispanic and/or Latino” when conducted in 
South America; and “Black” when conducted in African countries.  
Methodological Study Quality Assessment  
Included trials were assessed for methodological study quality using a modified version of 
the Downs and Black Checklist [57, 58] (see Appendix 3 for the augmented checklist). This 
instrument [59] is well validated in the health promotion literature and has been shown to be valid 
and reliable in assessing RCTs and non-RCTs. The Downs and Black Checklist [59] addresses five 
subscales of methodological quality: (1) reporting, (2) external validity, (3) bias, (4) confounding, 
and (5) power, making it one of the most comprehensive extant instruments to evaluate study quality 
[60]. Methodological study quality score was gauged as percentage of items satisfied out of a 
possible 29-point total. A similar approach was used to evaluate each study quality subscale, which 
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provided a summary of the methodological strengths and weaknesses for each study. Consistent with 
other reviews [57, 58], ranges in overall methodological study quality scores were grouped into three 
quality levels: low (≤14 points, <50%), moderate (>14 to 23 points, 50-79%), and high (≥24 points, 
≥80%). In addition to quantifying the overall quality of the dynamic RT literature, we examined how 
overall study quality (or individual quality items) influenced the BP response to dynamic RT 
independently or interactively [61] with other moderators. 
Study Outcomes, Effect Size Calculation, and Moderator Analyses 
The standardized mean difference effect size (d) was used to quantify the effectiveness of 
dynamic RT as stand-alone antihypertensive therapy, defined as the magnitude of change in resting 
SBP and DBP post- versus pre-intervention values, correcting for small sample size bias and baseline 
differences[62, 63] (see Appendix 4.1 for effect size estimations). Because our effect size estimate is 
in a comparable parameter, d, studies with different experimental designs (i.e., parallel study design 
versus within-in subject, cross-over design) were combined to maximize the number of studies in our 
sample, thus improving the power of our meta-analysis [64-66]. We disaggregated comparisons for 
trials with more than one RT intervention (e.g., high versus low intensity RT) [42-48]; effect sizes 
were calculated for each comparison and analyzed as separate studies [67]. To control for non-
independent effect sizes (i.e., RT studies with multiple treatment groups compared to a single control 
[68]), we performed alternative analyses using the Metafor package [69] for R [70] that accounted 
for these issues and yielded the same pattern of results. For simplicity of interpretation, we report the 
maximum likelihood estimation analyses for SBP and DBP. Negative d values indicated that 
dynamic RT reduced BP more than the non-exercise control/comparison group; the magnitude of the 
mean difference can be interpreted as -0.20, -0.50, and -0.80 for small, medium and large reductions 
in resting BP [71]. Last, we provided the equivalent BP change in mmHg as a supplement to the 
observed d in order to enhance the clinical relevance of our findings (see Appendix 4.3 for the 
methods used to calculate the raw metric in mmHg).  
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 We used Stata 13.1 (StataCorp, College Station, TX) [72] with macros for meta-analysis [67] 
to perform all statistical analyses, incorporating random-effects assumptions. We visually examined 
funnel plots for any asymmetries in the effect size distribution to identify potential publication or 
other reporting biases [73]. In addition, we tested our data for publication bias using Begg [74] (SBP: 
z=-0.46, p=0.64; DBP: z=-1.32, p=0.19) and Egger [75] (SBP: t=-1.30, p=0.20; DBP: t=-1.19, 
p=0.24) methods; no publication bias was detected by either test (See Appendix 19, Figure S3, for 
the Begg and Egger funnel plots). Inconsistencies in d values were estimated with the I2 statistic and 
its confidence intervals (95% CIs) [76, 77]. I2 values range from 0% (homogeneity) to 100% (greater 
heterogeneity). As I2 increases, homogeneity is less likely and heterogeneity is more likely; a CI that 
does not include 0% indicates that the hypothesis of homogeneity is rejected, and an inference of 
heterogeneity is merited [77, 78].  
Moderator analyses were used to explain variability in ds for SBP and DBP, using weighted 
regression models with maximum likelihood estimation of the random-effects weights, the inverse of 
the variance for each d. Continuous moderators were mean centered and categorical variables were 
contrast coded before generating interaction terms or examining multiple moderators simultaneously 
[61, 79]. Significant moderators identified with bivariate meta-regression analyses were combined in 
multiple moderator models for SBP and DBP and examined simultaneously to explain unique study 
variance. In each multiple moderator model, the moving constant technique [79] was used to estimate 
the magnitude of weighted mean effect sizes ( ) and their CIs at different levels of interest for 
individual moderators that represented a range of observations, including minimum and maximum 
values while statistically controlling for the presence of moderators. For both SBP and DBP, an 
additive model was generated from the final model that represented the greatest potential 
antihypertensive benefit that can be achieved with dynamic RT. Individual moderators and 
interaction terms were evaluated simultaneously at the level that conferred the greatest BP benefit 
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(i.e., greatest BP reductions), which in turn, demonstrated the combination of patient and RT 
characteristics that elicited optimal antihypertensive therapy. Finally, the proportion of between-
study variance explained by the model (i.e., Multiple R) and the residual unexplained variance (i.e., I2 
Residual) are provided (see Model Summary for Tables 2 and 3). Summary statistics are presented as 
Mean ± standard deviation (M ± SD) unless otherwise stated. Two-sided statistical significance was 
p<0.05. 
Results 
Study Characteristics  
RT interventions were published between 1987 and 2013 (2006.7±6.4), and were conducted 
in North American (32%, k=23), Asia (24%, k=17), Europe (20%, k=14), South America (17%, 
k=12), Australia (6%, k=4), and Africa (1%, k=1). Among the trials that reported sex/gender (two 
trials did not), 19 interventions involved all women (26.8%), 20 interventions involved all men 
(28.2%), and the remaining trials involved samples of mixed sex/gender (42.3%, k=30). The majority 
of RT interventions were RCTs (81.7%, k=58), but only half examined BP as a primary study 
outcome (47.9%, k=34). Of these, ~70% of RCTs used a parallel (i.e., between-subject) study design 
(k=50), two studies [50, 80] used a within-subject, cross-over design, and nine studies involved a 
“placebo” comparison group instead of a non-exercise or ‘wait-listed’ control. “Placebo” 
interventions included light/low intensity, full body stretching performed two [81, 82] or three days 
per week [26, 28, 83, 84], health education lectures that occurred weekly [27] or once every fourth 
week [52], or a supplement (i.e., sugar pill) was taken once daily [85].  
[INSERT FIGURE 1] 
 Included trials achieved “moderate quality” (~63% of items satisfied) [57, 58] despite widely 
varying methodological quality scores (41%-85%). (Appendix 14 summarizes the overall 
methodological study quality for the RT sample and how well RT interventions satisfied individual 
quality items). Trials were most likely to satisfying the reporting (78.6%±10.2%), internal validity-
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bias (70.2%±14.9%) and internal validity-confounding (51.5%±30.1%) quality subscales, but were 
least likely to satisfy external validity (46.5%±42.3) and power (9.2%±24.4%). None of the 
individual quality subscales emerged as significant moderators of the BP response to dynamic RT. 
Finally, only seven trials satisfied ≥80% of the Downs and Black study quality checklist items 
(83.3%±1.3%). (Appendix 15 describes the overall and itemized methodological study quality for 
each of the included dynamic RT trials).  
Sample Characteristics 
Dynamic RT (n=1,304) and control participants (n=1,070) were largely healthy (61%, k=43), 
sedentary, middle-aged (47.4±19.0 yr), overweight (26.7±3.5 kg·m-2) adults with prehypertension 
(SBP/DBP: 126.4±9.4/76.6±8.4 mmHg). Nonetheless, a smaller subset consisted of samples with 
CVD risk factors or known disease (27%, k=19) including: type 2 diabetes mellitus (3%, k=2), the 
metabolic syndrome (2%, k=1), dyslipidemia (2%, k=1), obesity (5%, k=3), CVD (2%, k=1), or 
combinations of chronic diseases and health conditions (15%, k=9). Included RT trials yielded a 
diverse sample with 56% (k=40) White (n=1,402) and 44% (k=31) non-White that included: 18% 
Hispanic/Latino (n=1,505), 24% Asian (n=521), and 1% African American (n=28). Approximately 
17% (n=222) of the RT sample was on antihypertensive medication, but approximately one-third of 
RT trials failed to disclose BP medication use (68% did). There were no differences in baseline 
sample characteristics between the dynamic RT and control groups (see Table 1).  
[INSERT TABLE 1 HERE] 
Dynamic Resistance Training Intervention Characteristics  
Dynamic RT interventions ranged from six to 48 weeks (14.4±7.9 weeks) and consisted of 
two to five sessions·week-1 (2.8±0.6 days·week-1). Dynamic RT was performed at moderate-intensity 
or levels of exertion that corresponded to 65-70% of one repetition maximum (% of 1-RM) 
(64.7±13.0% of 1-RM). Eleven trials (15.5%) failed to disclose RT intensity, and one used the 
OMNI-RT scale (see Appendix 16 for a general description of the RT programs). RT programs 
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generally targeted the whole body (91.0%, k=63); four interventions focused on the lower body, and 
one involved unilateral, upper body RT. Most RT programs reported using machine weights, free 
weights, or a combination of modalities (76.1%, k=54) to train muscles groups of the upper and 
lower body; however, RT interventions varied widely in their prescription of acute program variables 
(see Appendix 16). In general, RT interventions prescribed 2.8±0.9 sets∙exercise-1 (range: 1-5) of 
11.0±3.8 repetitions∙set-1 (range: 5-30) for 7.9±2.9 RT exercises per session (range: 1-16). Direct 
supervision was reported in 63% of the RT interventions (k=45), including one-on-one supervision 
and small group processes; 10% (k=7) reported a combination of supervised and unsupervised 
sessions, and 27% (k=19) of trials failed to disclose the level of supervision. The overall adherence to 
the RT intervention was high (92.3%±8.9%), but only 65% reported this detail (Appendix 16). 
Resting Blood Pressure Assessment 
Overall, included RT trials failed to disclose important details related to the resting BP 
assessment. Most RT interventions reported the BP assessment tool (81.7%, k=58); of these, two 
trials assessed ambulatory BP in addition to causal/clinic BP [22, 86]. BP measurements were taken 
in the seated (42.3%) or supine (26.8%) position, yet ~69% of RT interventions did not report these 
details. RT interventions were least likely to disclose the timing of pre-and post-BP assessments: 
only half (52.1%) reported the duration (minutes) of quiet rest preceding baseline BP assessment, and 
even fewer reported (19.7%) the duration (hours) between the last exercise bout and the final post-
intervention BP measurement. Appendix 17 provides a general description of the BP assessment 
details. 
Dynamic Resistance Training as Stand-Alone Antihypertensive Therapy 
Small to moderate reductions in SBP (d+=-0.31, CIs: -0.43 to -0.19; -3.0 mmHg) and DBP 
(d+=-0.30, CIs: -0.38 to -0.18; -2.1 mmHg) were observed following dynamic RT relative to control; 
and collectively, the effect sizes lacked homogeneity (SBP: I2=51%; 95% CIs: 36%-63% and DBP: 
I2=35%; 95% CIs: 13%-52%). Appendix 18 provides the weighted mean effect sizes and tests for 
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homogeneity (i.e., Cochran Q [87] and I2 [77, 78] statistics) for SBP and DBP. (See Appendix 20, 
Figure S4, for the contour-enhanced funnel plots, i.e., confunnels, for a visual representation of the 
effect size distribution for SBP and DBP).  
Moderator Analyses 
Bivariate meta-regression analyses revealed significant moderators for SBP and DBP related 
to sample, dynamic RT, and methodological quality characteristics. When combined in  multiple 
moderator models, significant bivariate models explained ≥50% of the observed heterogeneity in the 
BP response to dynamic RT (see Tables 2 and 3).  
Five moderators explained unique variance relating to the effectiveness of dynamic RT to 
reduce SBP when entered in a multiple regression model, accounting for ~67% of the between-study 
variance. SBP reductions were greater among samples with higher resting SBP (p=0.011), which 
occurred in a dose response fashion: -5.7 mmHg for hypertension, -3.0 mmHg for prehypertension, 
and 0.0 mmHg for normal SBP. SBP was also reduced to a greater extent among Non-White (-4.7 
mmHg) than White samples (0.0 mmHg) (p=0.002), and among samples who were not taking BP 
medication (-4.3 mmHg) compared to those that were (-0.4 mmHg) (p=0.034). Finally, greater SBP 
reductions occurred following RT programs that involved ≥8 versus <8 RT exercises per session (-
4.4 versus -1.4 mmHg, respectively) (p=0.043) and among trials that had BP-focused primary 
outcomes versus those that did not (-3.9 versus -0.8 mmHg, respectively) (p=0.032) (see Table 2). 
The greatest SBP reductions occurred among samples with untreated hypertension who performed ≥8 
RT exercises per session (-11.8 mmHg, 95% CI: -16.0, -7.4), an effect that was significantly greater 
among non-White (-14.3 mmHg) than White samples (-9.2 mmHg) (Table 2, Additive Model).  
[INSERT TABLE 2 HERE] 
Four moderators explained unique variance relating to the effectiveness of dynamic RT to 
reduce DBP when entered in a multiple regression model, accounting for ~50% of the between-study 
variance. DBP reductions were greater among samples with higher resting DBP (p=0.023): -5.2 
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mmHg for hypertension, -3.3 mmHg for prehypertension, and -1.0 mmHg for normal DBP. DBP was 
also reduced to a greater extent among samples who were not taking BP medication (-3.5 mmHg) 
compared to those that were (-1.2 mmHg) (p=0.028). Last, greater DBP reductions occurred when 
dynamic RT was performed ≥3 versus <3 days∙wk-1 (-4.5 versus -0.9 mmHg, respectively) (p=0.02), 
and among trials that achieved lower than higher study quality (-3.7 versus -0.3 mmHg, respectively) 
(p=0.019) (See Table 3). The greatest DBP reductions occurred among samples with untreated 
hypertension who performed RT on 3 or more days·week-1 (-9.9 mmHg, 95% CI: -13.9, -5.9), an 
effect that was slightly more pronounced among non-White (-10.3 mmHg) than White samples (-9.2 
mmHg) (Table 3, Additive Model).  
 [INSERT TABLE 3 HERE] 
Discussion 
The present meta-analysis aimed to determine the efficacy of dynamic RT as stand-alone 
antihypertensive therapy, and to identify potential moderators of the BP response to provide insight 
into the optimal dose of RT to lower BP among adults with hypertension. Consistent with prior meta-
analyses [6, 8-11], overall, we found that moderate-intensity dynamic RT on average reduced BP ~2-
3 mmHg compared to control (ps<0.001). Importantly, our moderator analyses revealed new findings 
that merit further comment. We found the BP reductions following RT occurred in dose response 
fashion such that greater BP reductions occurred among samples with hypertension (~6/5 mmHg) 
followed by prehypertension (~3/3 mmHg), and normal BP (~0/1 mmHg) (ps≤0.023). Dynamic RT 
elicited BP reductions that were comparable to those observed with aerobic exercise training among 
adults with hypertension. Furthermore, non-White samples with hypertension achieved even larger 
BP reductions, approximately double the magnitude reported following aerobic exercise (~10-14 
mmHg). Our results indicate that for adults with hypertension, notably non-White (i.e., 
Hispanic/Latino and Asian) samples, dynamic RT may be as or even more effective than aerobic 
 65 
 
exercise training in lowering BP. Due to the novel nature of our findings, RT should be further 
investigated as a viable stand-alone therapeutic exercise option for adults with hypertension.  
Presently, 30-60 min∙day-1 of moderate intensity aerobic exercise is recommended on most 
days of the week supplemented by dynamic RT on ≥2 days∙wk-1 [6, 12-15] as first-line 
antihypertensive therapy to lower BP 5-7 mmHg among adults with hypertension. Dynamic RT is 
recommended as adjuvant antihypertensive lifestyle therapy to aerobic exercise training because 
there is a weaker body of evidence indicating it lowers BP to lesser levels among adults with 
hypertension [5, 8-11, 16, 17]. Yet, our meta-analysis, which that adhered to high-quality 
methodological standards, revealed that  the magnitude of the BP reductions resulting from dynamic 
RT are comparable to or greater than those achieved with aerobic exercise training among adults with 
hypertension, particularly for non-White samples. Accordingly, our results indicate that the present 
exercise recommendations for hypertension should be revisited to include dynamic RT (in addition to 
aerobic exercise) as stand-alone antihypertensive lifestyle therapy. 
Our meta-analysis adds other new information to the literature, namely we are the first to 
identify important moderators of the BP response to dynamic RT. Our most noteworthy and 
clinically relevant finding was that dynamic RT elicited BP reductions in dose-response fashion, 
findings that align with those reported for aerobic exercise training [4-6], but not with other meta-
analyses examining the BP response to RT. Reasons for the differences observed in our meta-
analysis compared others are not completely clear but may reside in the fact that we performed one 
of the largest and most comprehensive electronic searches to date, included RCT and non-RCTs, and 
identified twice the number of RT interventions involving adults with hypertension (k=8) [20-24, 52, 
88, 89] than previously reported (k=4) [8]. Furthermore, the other meta-analyses examined potential 
moderators of the BP response to RT using subgroup analysis, which lacks the sensitivity and 
precision needed to detect small exercise-related changes in BP [90, 91]. We applied conventional 
meta-analytic techniques (i.e., meta-regression) and more sophisticated approaches, i.e., multiple 
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moderator models [92, 93] and the moving  constant technique [79], which allowed us to estimate BP 
changes at different levels of individual moderators (i.e., sample and RT characteristics) and 
provided greater clinical translation. Second, we quantitatively incorporated and examined whether 
study quality independently [4, 18] or interactively [61] modulated the BP response to dynamic RT. 
We found that BP reductions were greater among trials that achieved lower than higher study quality, 
although, only seven RT trials [32, 50, 80-82, 94, 95] were considered to be of ‘higher’ quality 
satisfying ≥80% of the quality items. We also found that, despite overall quality, greater BP 
reductions occurred among trials that had BP-focused primary outcomes versus those that did not. 
We, along with prior meta-analyses [8, 11, 17], have found this literature to be of ‘fair to 
moderate’ methodological quality [57, 58]. In the absence of a higher quality literature, there is the 
potential risk of bias or other threats to the validity of our findings. Therefore, it is also noteworthy to 
mention that in addition to study quality, we also examined other sources of potential bias related to 
the Downs and Black quality subscales, whether trials had BP-focused outcomes, and if our results 
differed based on the publication year, type of trial (i.e., RCT versus non-RCT), number of RT 
interventions (i.e., single versus multiple RT groups), or number of funding sources. We then 
statistically examined whether these potential biases modulated the BP response to AET; even when 
these features were non-significant in bivariate meta-regression models, we incorporated them (when 
possible) to control for confounding or suppression effects that could arise from lower-quality trials 
[4, 61]. We found that higher study quality was associated with trials that: were published more 
recently (r=0.45, p<0.001), were RCTs (versus non-RCTs) (r=0.23, p=0.052), were adequately 
powered to detect BP outcomes (Downs and Black Checklist Item 28) (r=0.41, p<0.001), compared 
a single-RT intervention to control (versus multiple RT groups) (r=0.22, p=0.069), and followed 
standard protocols or established guidelines when measuring BP (i.e., American Heart Association 
Council on High BP Research Part 1: Recommendations for BP measurement in Humans [96]) 
(r=0.24, p=0.045). Not surprisingly, trials that used standard protocols/established guidelines when 
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assessing BP also used more reliable and accurate BP assessment methods (Downs and Black 
Checklist Item 21) (r=0.76, p<0.001). Interestingly, trials that were adequately powered (Downs and 
Black Checklist Item 28) also received greater funding support (r=0.26, p=0.029). By examining the 
potential risk of bias from several sources and incorporating them into our multiple moderator 
models (i.e., study quality, BP-focused outcomes, number of RT interventions) we can be more 
confident in our study results despite the number of methodological deficits and inconsistencies we 
have documented in this literature. 
Through our moderator analyses, we also addressed other noteworthy gaps in this literature. 
No meta-analysis conducted to date has identified features of the exercise intervention that 
influenced the BP response to dynamic RT, which in part, may be attributed to the poor disclosure of 
important RT intervention features. For example, most of the included trials reported the number of 
RT exercises (97% did), sets (94% did) and repetitions (92% did) performed at each session, yet only 
half reported the RT intensity as a percentage of 1-RM (~54%), and even fewer trials reported the 
duration of rest intervals prescribed between sets and/or exercises (~42%). Because BP increases 
proportionally to effort [97], muscle mass activation [98-101], intensity and duration of the set 
(especially those performed to failure [98, 101-103]), and decreases during rest intervals when blood 
flow is restored to working muscles [97, 101, 104, 105], the omission of specific RT features (i.e., 
acute program variables) adds to the lack of knowledge regarding what RT programs have the most 
favorable BP, and more generally, cardiovascular, benefit for adults with hypertension. Furthermore, 
one-third of RT programs did not incorporate fundamental strength and conditioning principles [97, 
106], such as “progressive overload” (i.e., gradual increase in RT intensity/load; repetitions; RT 
volume; or introduction of more complex lifting techniques) (34% did) or “specificity” (28% did). 
Indeed, nearly 70% of all trials did not report RT progression (38%) or provided few details 
regarding how progression occurred (28%) that replication of the RT prescription is impossible. 
Given that training adaptations are specific to the stimulus applied (i.e., principle of specificity), it is 
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troubling that the majority of trials failed to report any rationale or theoretical basis for their RT 
program design. Nonetheless, in agreement with the current exercise recommendations for 
hypertension, we found that low to moderate-intensity RT programs (~60-65% of 1-RM; 8-15RM; 4-
5 MET) consisting of ~3 sets of 10-12 repetitions for ~8 exercises (3-4 upper and 4-5 lower body 
exercises) performed ~3 days∙wk-1 for 14 weeks significantly reduced resting BP ~5-6 mmHg among 
adults with hypertension. We observed even greater BP reductions following RT programs that 
involved ≥8 versus <8 RT exercises per session, and when dynamic RT was performed ≥3 versus <3 
days∙wk-1. Even so, important features of the RT intervention (i.e., RT intensity/load, rest interval 
duration, etc.) were inconsistently reported so that the optimal FIT exercise prescription for dynamic 
RT among adults with hypertension is not clear (Appendix 16).  
We also identified patient characteristics that may benefit the most from dynamic RT as 
stand-alone antihypertensive therapy. Namely, BP reductions were greater among samples who were 
not taking antihypertensive medications (~4 mmHg) compared to those that were (~1 mmHg). 
Although some studies have reported a synergistic effect between BP medication and the BP 
reductions following RT [29, 107, 108], others have found no difference in the resultant BP 
reductions between the two [21, 22, 30]. It is noteworthy to mention that only a small proportion of 
our RT sample was currently taking BP-lowering medications (~17%); this may be a reflection that 
approximately one-third of RT trials failed to disclose medication use, and the smaller number of 
samples with hypertension (~11%; k=8) than prehypertension (~71%; k=50) and normal BP (~18%; 
k=13) in our meta-analysis. 
We found that dynamic RT elicited BP reductions that were comparable to or greater than 
those achieved with aerobic exercise training among adults with hypertension, particularly for non-
White samples (i.e., Asian, Hispanic/Latino and African American), who achieved BP reductions 
approximately double the magnitude (~10-14 mmHg) associated with aerobic exercise training. To 
the best of our knowledge only one meta-analysis [56] has investigated the potential impact of 
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ethnicity/race on the BP response to exercise training. Whelton and colleagues [56] found that 
aerobic exercise training reduced resting BP to greater levels among Asian (6/7 mmHg) and Black 
(11/3 mmHg) compared to White samples (3/3 mmHg) (p<0.05). We observed a similar trend where 
greater BP reductions occurred among Hispanic/Latino (~13/10 mmHg; k=14) and Asian (~11/10 
mmHg; k=12) compared to White samples (~9/10 mmHg; k=40), differences that achieved statistical 
significance only when examined collectively as non-White versus White samples. These findings 
are important because certain Hispanic/Latino and Asian populations experience a disproportionate 
burden of obesity and hypertension-related diseases [1, 109, 110], and these health disparities are 
further exacerbated by lower cardiorespiratory fitness levels and  more sedentary lifestyles [1, 111-
113] compared to Whites. Therefore, Hispanic/Latino, Asian and other racial/ethnic minority 
populations are less likely to engage in exercise as antihypertensive therapy despite the fact our 
findings showed they are the patients who may benefit the most. Our findings are promising in that 
they provide another viable therapeutic exercise option that can be performed in addition to aerobic 
exercise as stand-alone antihypertensive lifestyle therapy. 
Even though we examined several sources for potential biases, of which some addressed the 
validity of the BP assessment methods used, it important to stress the poor reporting of these 
variables in this literature. Several reviews [4-6, 114] have commented on how the level of reporting 
and quality of BP assessment procedures may contribute to the discrepancies observed across studies 
in the magnitude of the BP reductions following exercise (i.e., unaccounted sources of 
heterogeneity). Yet, ~31% of RT interventions failed to disclose any BP assessment procedures, 
while ~20-30% of RT trials failed to report specific details that included: the type of BP monitor or 
assessment tool (82% did), the body position during the BP measurement (69% did), and the timing 
of BP measurements at baseline (52% did) and post-intervention (20% did). At this time, it is unclear 
how the poor reporting and variability in these parameters influenced our results. 
 70 
 
In summary, our high quality methodological meta-analysis, which adhered to contemporary 
standards, revealed that dynamic RT is as effective if not more so than aerobic exercise as 
antihypertensive therapy among those with hypertension, notably non-White samples. These results 
indicate that the present exercise recommendations for hypertension should be revisited to include 
dynamic RT (in addition to aerobic exercise) as stand-alone antihypertensive lifestyle therapy. 
Despite these promising findings, this body of literature is of fair to moderate quality with other 
limitations noted within. Additional RCTs are needed to investigate RT as a viable stand-alone 
therapeutic exercise option among more ethnically/racially diverse samples with hypertension. 
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Table 1. Summary of the baseline characteristic for dynamic resistance training and 
non-exercise control groups.  
Characteristic   k  
Dynamic RT 
 (n=1, 304)  k 
 Control  
(n=1, 070) 
Women (%)  69  48.7 (39.1, 58.3)  68  49.3 (39.5, 59.0) 
Age (years)  68  47.2 ± 19.0  67  47.2 ± 19.1 
BP Medication (% using)  48  14.1 (5.6, 22.5)  48  12.3 (4.5, 20.0)  
Race/Ethnicity, % (n)          
White   40  56.3 (774)  40  56.3 (628) 
Asian   17  23.9 (263)  17  23.9 (258) 
Hispanic/Latino/Caribbean  13  18.3 (254)  13  18.3 (251) 
African American/Black  1  1.4 (13)  1  1.4 (15) 
Sedentary (%)  54  92.6 (85.4, 99.8)  53  92.4 (85.1, 99.8)  
Body Composition         
Body weight (kg)  61  75.0 ± 11.7   59  74.1 ± 12.0  
Body Mass Index (kg∙m-2)  60  26.8 ± 3.4   58  26.6 ± 3.7  
Waist circumference (cm)  17  96.9 ± 9.3   17  96.1 ± 10.0  
Body Fat (%)  36  29.7 ± 6.9   36  29.3 ± 7.9  
Fat Mass (kg)  11  26.4 ± 6.8  11  26.7 ± 7.2 
Lean Mass (kg)  20  50.9 ± 11.2  20  49.4 ± 11.1 
Resting Hemodynamics          
Systolic BP (mmHg)  71  126.7 ± 10.3   70  126.3 ± 9.4  
Diastolic BP (mmHg)  71  76.8 ± 8.7   70  76.5 ± 8.6  
MAP (mmHg)  71  93.2 ± 8.0   70  93.2 ± 8.2  
Pulse Pressure (mmHg)  71  49.4 ± 8.3   70  49.8 ± 6.8  
Heart rate (beats∙min-1)  41  70.1 ± 6.9   40  69.1 ± 7.3  
Strength and Fitness Measures         
Upper body strength (kg) *  18  44.5 ± 31.3   10  43.4 ± 36.5  
Lower body strength (kg) †  24  92.3 ± 58.8   16  97.3 ± 69.7  
Cardiorespiratory Fitness ‡  37    36   
Oxygen Uptake (ml∙kg∙min-1)  24  28.6 ± 9.9   23  29.7 ± 9.4  
Note. Based on 71 observations (k). Summary statistics are presented as Mean ± Standard 
Deviation or as Mean (Lower, Upper 95% Confidence Interval). Abbr. BP=Blood pressure. 
MAP=Mean arterial pressure. RT=Resistance training. * Upper body strength was assessed in 
25 RT and 14 Control groups; k=18 and k=10 quantified pre-intervention strength in kilograms. 
† Lower body strength was assessed in 33 RT and 24 Control groups; k=24 and k=16 
quantified pre-intervention strength in kilograms. ‡ Fitness was assessed in 37 RT and 36 
Control groups; k=24 and k=23 measured pre-intervention fitness as peak or maximal oxygen 
uptake. 
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Chapter 4 
Discussion 
The present dissertation includes two meta-analyses that aimed to determine the influence of 
modality on the antihypertensive effects of exercise and to identify what combinations of patient 
clinical characteristics and exercise intervention features elicited optimal therapeutic BP benefit. This 
chapter provides a summary of our most relevant findings and serves as the concluding statement on 
the antihypertensive effects of AET and dynamic RT. First, we will overview our major findings as 
they relate to our specific aims and hypotheses. This will be followed by a discussion on the 
implications of our findings on the current exercise recommendations for adults with hypertension. 
Finally, we will discuss the remaining gaps in the existing literature and present potential directions 
for future research. 
4.1 Specific Aims and Hypotheses 
The results from these two meta-analyses support our initial specific aims and hypotheses for 
outlined in Chapter 1. Below find a reiteration of our major findings for AET and dynamic RT in the 
context of our specific aims and hypotheses.   
 Specific Aim 1: To meta-analyze the existing AET literature with high quality methods to 
determine the effectiveness of AET as an antihypertensive therapy and identify what patient clinical 
and AET FIT characteristics elicit optimal antihypertensive BP benefit.  
 Hypothesis 1: Patient clinical (i.e., age, body mass index, sex/gender, race/ethnicity, BP 
medication use, etc.) and AET FIT characteristics will moderate the antihypertensive effects of AET.  
 We observed that AET on average reduced BP by ~3-4 mmHg compared to control. Of note, 
we found that BP reductions occurred in dose response fashion such that greater BP reductions were 
observed among samples with hypertension (~7/6 mmHg) than prehypertension (~5/4 mmHg), and 
normal BP (~3/1 mmHg). Furthermore, even larger BP reductions were observed among samples 
with hypertension that achieved large gains in physical fitness and performed high volumes of AET, 
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an effect that was more pronounced among non-White (~12 mmHg) than White (~6-7 mmHg) 
samples. Our results confirm the effectiveness of AET as antihypertensive lifestyle therapy for adults 
with hypertension, notably among African American (i.e., non- Hispanic Blacks), Asian, and 
Hispanic/Latino samples, who achieved BP reductions that nearly doubled the magnitude previously 
reported for AET.  
 Specific Aim 2: To meta-analyze the existing dynamic RT literature with high quality methods 
to determine the effectiveness of RT as stand-alone antihypertensive therapy and identify important 
moderators (i.e., patient clinical and RT FIT characteristics) of the BP response to provide insight 
into the optimal dose of RT to lower BP among adults with hypertension.  
 Hypothesis 2: Patient clinical (i.e., age, body mass index, sex/gender, race/ethnicity, BP 
medication use, etc.) and RT FIT characteristics will moderate the antihypertensive effects of 
dynamic RT and provide insight into the optimal dose of RT as stand-alone antihypertensive therapy 
for adults with hypertension.  
We observed that dynamic RT on average reduced BP by ~2-3 mmHg compared to control. 
However, we found that BP reductions occurred in dose response fashion such that greater BP 
reductions were observed among samples with hypertension (~6/5 mmHg) than prehypertension 
(~3/3 mmHg), and normal BP (~0/1 mmHg). Furthermore, even larger BP reductions were observed 
among samples with hypertension following RT that involved ≥8 RT exercises per session and was 
performed 3 or more days·week-1, an effect that was more pronounced among non-White (~10-14 
mmHg) than White (~9-10 mmHg) samples. Our results revealed that dynamic RT is as effective if 
not more so than AET as antihypertensive therapy among those with hypertension, notably 
Hispanic/Latino and Asian samples. These results indicate that the present exercise recommendations 
for hypertension should be revisited to include dynamic RT (in addition to aerobic exercise) as stand-
alone antihypertensive lifestyle therapy.  In addition, high quality RCTs should be designed to further 
substantiate our findings.  
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4.2 Additional Findings 
In addition to our major findings detailed above, we also observed several interesting patterns 
related to the overall methodological study quality of the included trials, and sources of potential bias 
that may have contributed more substantially to the “fair to moderate” quality of the AET and 
dynamic RT literature. Overall, we found that primary-level AET and RT interventions included in 
our meta-analyses achieved similar methodological study quality (~65% and 63%), and for both 
modalities, there was considerable range in percentage of quality items that were fully satisfied, with 
overall methodological quality ranging from low (40%) to high (86%) [1, 2]. Surprisingly, only two 
AET interventions satisfied ≥80% of study quality items (83.6%±2.8%), which suggests ‘higher 
quality’, whereas seven RT trials achieved ≥80% (83.3%±1.3%). 
Overall, AET and RT interventions yielded similar patterns regarding methodological deficits 
and potential risk of biases gauged as the percentage of items fully satisfied using an augmented 
version of the Downs and Black Checklist. This instrument [3] is well validated in the health 
promotion literature and has been shown to be valid and reliable in assessing RCTs and non-RCTs. 
The Downs and Black Checklist [3] addresses five subscales of methodological quality, making it 
one of the most comprehensive extant instruments to evaluate study quality [4]. The methodological 
subscales address potential risk for bias as it relates to: (1) reporting (i.e., how well were the 
intervention details and other important information reported so that readers could make an unbiased 
assessment of the study findings); (2) external validity (i.e., addresses the extent to which the study 
findings can be generalized to the population from which the study subjects were derived); (3) 
internal validity-bias (i.e., addresses the biases associated with the measurement of the intervention 
and the study outcomes); (4) internal validity-confounding (i.e., addresses the bias in the selection of 
study subjects); and (5) power (i.e., assesses whether the negative findings from a study could be due 
to chance, i.e., inadequately powered sample to detect study findings) [3]. AET and RT interventions 
were least likely to satisfy the methodological subscales that addressed external validity (AET: 
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49.6%±40.7; RT: 46.5%±42.3) and power (AET: 1.7%±11.7%; RT: 9.2%±24.4%). None of the 
individual methodology quality subscales emerged as significant moderators of the BP response to 
AET or dynamic RT. These findings highlight the significant limitations of the existing exercise and 
hypertension literature, namely that primary-level interventions lack the ability to generalize their 
findings to the population from which the study subjects were derived (i.e., poor external validity) 
and trials were not designed based on the sample size needed to detect exercise-related BP changes 
[5, 6]. As a result, research syntheses, i.e., meta-analyses, of these exercise interventions may be 
subject to the same limitations. Furthermore, exercise interventions that fail to fully satisfy these 
particular subscales add to the uncertainty and discrepancies observed across trials in the magnitude 
of BP reductions following exercise. It is unclear whether exercise interventions fail to observe 
significant BP reductions as a result of the Ex Rx employed the clinical population enrolled, or a 
small sample that was inadequately powered. Indeed, despite our meta-analyses constituting some of 
the largest samples to date [7], only 26% (k=27) of AET and 11% (k=8) of RT interventions involved 
adults with hypertension and sample sizes on average were small (n=18-20 participants). 
Furthermore, we found that nearly 12% (k=10) of AET and 14% (k=9) of the RT trials 
incorporated a “placebo” or “active control” group instead of a, non-exercise or “wait-list” condition. 
Although this study design feature did not emerge as a significant moderator in either meta-analysis, 
it may have underestimated the antihypertensive effects of AET and dynamic RT. BP reductions 
were significantly smaller when compared to the placebo or active control groups (AET: -3.4/+0.8 
mmHg; RT: +0.1/-0.3 mmHg) than all control groups (AET: -3.5/-2.7 mmHg; RT: -3.0/-2.1 mmHg).  
4.3 Implications for the Exercise Prescription Recommendations for Hypertension 
Based on the synthesis of the AET and dynamic RT literature presented in each meta-
analysis, the following FITT-VP Ex Rx guidelines are suggested as a possible modification or 
expansion of the current exercise recommendations for hypertension: 
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Frequency: AET reduced resting BP to the greatest extent among adults with hypertension (~6-7 
mmHg). These reductions occurred with AET performed ~3-4 days·week-1. Accordingly, AET 
should be performed on at least 3 days·week-1, preferably most days of the week, to achieve 
optimal BP benefits. These recommendations are consistent with the current ACSM 
recommendations for hypertension [8] and other professional organizations/committees [6]. 
Frequency: Dynamic RT reduced resting BP to the greatest extent among adults with hypertension 
(~5-6 mmHg). These reductions occurred with RT regimes that were performed ~3 days·week-1. 
However, we observed greater BP reductions when RT was performed on 3 or more days·week-1. 
Accordingly, dynamic RT should be performed 3-4 days·week-1 (in addition to aerobic exercise) 
as stand-alone antihypertensive lifestyle therapy. These recommendations are a departure from the 
current ACSM recommendations for hypertension [8] and other professional 
organizations/committees [8-12] that who endorse dynamic RT on ≥2 days∙week-1 as adjuvant 
antihypertensive lifestyle therapy to AET.  
Intensity: AET performed at moderate-to-vigorous intensity (62.6%±10.6% VO2peak [range: 40-83% 
VO2peak]; 5.9±1.7 MET [range: 3-12 MET]) elicited BP reductions of ~6-7 mmHg among adults 
with hypertension. Nonetheless, high exercise volumes achieved with higher intensity (~8 MET) 
were more efficacious as antihypertensive among adults with hypertension (~9-12 mmHg). Our 
findings contribute to the growing body of literature that supports greater BP reductions can be 
achieved with greater levels of exertion, if the patient is willing and able to tolerate higher levels 
of exertion [13-15]. These recommendations align with ACSM [8] and others [6], and are 
consistent with the Lifestyle Work Group [10] and American Heart Association [9], who also 
endorse vigorous or high-intensity exercise.  
Intensity: Dynamic RT performed at low-to-moderate intensity (64.7%±13.0% of 1-RM [range: 40-
80% of 1-RM]; range in 1-RM values: 8-15RM; 4.7±1.8 MET [range: 3-8 MET]) was sufficient to 
elicit BP reductions of ~5-6 mmHg among adults with hypertension. However, we observed RT 
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programs that involved ≥8 versus <8 RT exercises per session were more efficacious as stand-
alone antihypertensive among adults with hypertension (~9-14 mmHg). These RT programs 
consisted of a greater number of upper (6 versus 3 exercises·session-1) and lower body (5 versus 4 
exercises·session-1) (ps<0.001), a higher number of repetitions performed per set (13 versus 10 
repetitions·set-1, p=0.038), and shorter rest intervals between sets and exercises (30-60 versus 90-
120 seconds, p=0.021) than RT programs involving <8 exercises per session. Nonetheless, many 
important features of the RT intervention were inconsistently reported, missing, or ranged 
considerably across trials so that the optimal FIT for dynamic RT as stand-alone antihypertensive 
therapy remains unclear [16, 17]. These recommendations are consistent with the current RT 
recommendations for healthy adults [18], and adults those with hypertension put forth by the 
ACSM [8] and other professional organizations/committees [8-12].  
Time: AET performed for ~40 min·session-1 was sufficient in lowering resting BP ~6-7 mmHg 
among adults with hypertension. Based on the recommended AET Frequency, adults with 
hypertension should accumulate ~120-200 min·week-1, which is consistent with the current 
exercise recommendations of ≥150 min·week-1 [6, 8].  
Time: Dynamic RT programs that consisted of ~3 sets of 10-12 repetitions for ~8 exercises (3-4 
upper and 4-5 lower body exercises) significantly reduced resting BP ~5-6 mmHg among adults 
with hypertension. Overall, the average RT duration was not widely reported (~52% did; k=37), 
but of those that did, RT sessions lasted ~40-50 min∙session-1. Based on the recommended RT 
Frequency, adults with hypertension should accumulate ~120-200 min·week-1, which aligns with 
the exercise recommendations for hypertension [8] and for RT for healthy adults [18].  
Type: AET should emphasize dynamic, aerobic activities such as walking, jogging, swimming, 
running, and cycling [8]. Dynamic RT should target the major muscle groups of the upper and 
lower body and can be performed using machine or free weights using a conventional or circuit-
style training approach [8, 18]. 
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Volume: AET volume on average totaled ~850 MET∙min∙week-1 and elicited BP reductions of 6-7 
mmHg among adults with hypertension. However, AET consisting of high volumes of exercise 
(~1200 MET∙min∙week-1) were most efficacious in reducing BP among adults with hypertension 
(~9-12 mmHg), notably among non-White samples (~12 mmHg). It is noteworthy to mention that 
in our meta-analysis, high AET volume was achieved with more rigorous intensity AET (~8 
MET) performed on 3-5 days·week-1 for 30-40 min·session-1, and not through combinations of 
lower intensity, higher frequency (>5 days·week-1) and longer duration (>40 min·session-1) AET. 
This volume of exercise is within the range ACSM recommends for healthy adults (500-≥1000 
MET∙min∙week-1) [19]. Nonetheless, our results support that higher volumes of exercise appear to 
maximize the antihypertensive benefit of AET for adults with hypertension. Dynamic RT that 
consisted of ~3 sets of 10-12 repetitions for ~8 exercises (~45 min∙session-1), performed at low-to-
moderate intensity on 3-4 days∙week-1  totaled on average ~575 MET∙min∙week-1 (calculated as 
Frequency × Intensity [MET] × Time). This volume of RT elicited BP reductions of 5-6 mmHg 
among adults with hypertension and is consistent with ACSM’s recommendations for healthy 
adults (500-≥1000 MET∙min∙week-1) [19] . 
Progression: Overall, the FITT-VP principle of the Ex Rx for healthy adults is applicable for those 
with hypertension. Modifications may need to be made to the Ex Rx under circumstances such as; 
a) improvement or worsening of BP control; b) development of co-morbid conditions; c) changes 
to BP or other medication use; and/or d) injury or physical disability. In general, the ACSM 
special considerations for AET and dynamic RT are still applicable and should be followed as 
necessary [14, 19]. The progression of AET and dynamic RT should be gradual, and tailored to 
individual patient’s ability and tolerance [14, 19].  
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4.4 Additions to the Existing Literature    
4.4.1 Aerobic Exercise Training  
Our meta-analysis adds new and important contributions to the scarce body of literature that 
has identified patient characteristics ( i.e., resting BP [20-23],  race/ethnicity [24], age [25], and 
sex/gender [23]) and aspects of the FIT [25, 26] that modulate BP reductions following AET. We 
confirmed that AET is effective antihypertensive therapy for adults with hypertension, and that AET 
elicits BP reductions in a dose-response fashion such that the greatest BP reductions were observed 
among samples with hypertension (~7/6 mmHg) followed by prehypertension (~5/4 mmHg), and 
normal BP (~3/1 mmHg) [20-23]. In addition, we found AET programs that elicited large fitness 
gains (>25% to ~50%) and promoted high volumes of exercise (~1200 MET∙min∙week-1) maximized 
the antihypertensive benefits of AET among adults with hypertension (~9 mmHg), an effect that was 
more pronounced among non-White (~12 mmHg) than White (~6-7 mmHg) samples.  
Our most noteworthy and clinically relevant findings were that: (1) moderate-vigorous 
intensity AET reduced BP in a dose-response fashion, (2) large gains in physical fitness and high 
volumes of exercise elicited the greatest BP reductions among adults with hypertension, which are 
larger than previously reported, and (3) the antihypertensive benefits of AET were greatest among 
non-White samples, notably African American (i.e., non- Hispanic Blacks), Asian, and 
Hispanic/Latino populations, with hypertension that achieved BP reductions approximately double 
the magnitude (~12 mmHg) previously reported for AET. 
4.4.2 Dynamic Resistance Training 
Our meta-analysis adds novel information to the existing literature, namely that we are the 
first to document that RT reduces BP in dose-response fashion such that the greatest BP reductions 
occurred among samples with hypertension (~6/5 mmHg), followed by prehypertension (~3/3 
mmHg), whereas those observed among samples with normal BP were negligible (~0/1 mmHg). 
Second, we are the first to identify features of the RT FIT that influenced the BP response to dynamic 
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RT. In agreement with the current exercise recommendations for hypertension, we found that low-to-
moderate-intensity RT programs (~60% of 1-RM) consisting of ~3 sets of 10-12 repetitions for ~8 
exercises (3-4 upper and 4-5 lower body exercises) performed on ~3 days∙wk-1 significantly reduced 
resting BP ~5-6 mmHg among adults with hypertension. However, we observed the greatest BP 
reductions among adults with hypertension following RT programs that involved ≥8 versus <8 RT 
exercises per session, and when dynamic RT was performed ≥3 versus <3 days∙wk-1, (~9-14 mmHg), 
an effect that was more pronounced among non-White samples (i.e., Hispanic/Latino and Asian). Our 
most noteworthy and clinically relevant findings were that: (1) dynamic RT elicited BP reductions 
that were comparable to or greater than those achieved with AET among adults with hypertension, 
particularly among non-White samples, and (2) RT reduced BP  in dose-response fashion, findings 
that align with those reported for AET [6-8], but not with other meta-analyses examining the BP 
response to RT. Our findings suggest that dynamic RT prescribed with the FIT recommendations 
above may be recommended as stand-alone antihypertensive therapy among adults with hypertension 
similar to the AET recommendations, however, new RCTs should be conducted to confirm this 
proposition. 
4.4.3 Exercise Training Literature 
Aerobic exercise training (AET) is universally recommended as first line antihypertensive 
lifestyle therapy due to the strong level of evidence supporting it lowers blood pressure (BP) 5-7 
mmHg among most adults with hypertension [27]. Dynamic RT is recommended as adjuvant 
antihypertensive lifestyle therapy to aerobic exercise training because there is a weaker body of 
evidence indicating it lowers BP to lesser half that of AET among adults with hypertension (~2-3 
mmHg) [6, 26, 28-32]. Therefore, the American College of Sports Medicine [8] and other 
professional organizations and committees [9-12, 33] recommend 30-60 min∙day-1 of moderate 
intensity (i.e., 40% to <60% maximal oxygen consumption) AET on most days of the week 
supplemented by dynamic RT on ≥2 days∙wk-1 [8-12] as first-line antihypertensive therapy for the 
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prevention, treatment, and control of hypertension. Yet, a more critical review of this literature 
revealed considerable variability in the magnitude of the BP reductions from these recommendations 
for both AET (i.e., 1-9 mmHg) [6] and dynamic RT (i.e., 0-6 mmHg) [8, 28, 30, 32]. Reasons for 
inter- and intra-individual variability are not clear not clear [6, 9] but may be attributable to 
differences in baseline sample clinical and exercise intervention characteristics (i.e., the FITT) of the 
Ex Rx. Nonetheless, few meta-analyses have documented significant moderation patterns pertaining 
to these characteristics [6, 7]. 
Our two meta-analyses addressed several of the research gaps noted above, notably, the fact 
we identified combinations of patient clinical and FIT characteristics that optimized the 
antihypertensive BP benefits following AET and dynamic RT among adults with hypertension. Some 
of our findings contradict earlier statements made by the ACSM in their evidence-based position on 
exercise and hypertension [8]. In particular, our findings related to race/ethnicity. In contrast to the 
Category B level of evidence rating (i.e., fewer RCTs trials with inconsistent findings) and their 
conclusion that “race/ethnicity does not modulate the BP response to exercise training”, we found 
that greater BP reductions occurred among non-White (i.e., African American, Hispanic/Latino, and 
Asian) than White samples following AET and RT. Collectively, these findings are important 
because racial/ethnic groups often experience a disproportionate burden of hypertension and CVD 
[34]. These health disparities are further exacerbated by lower cardiorespiratory fitness and more 
sedentary lifestyles [34-37] compared to Whites. Thus, racial/ethnic minority populations are less 
likely to engage in regular exercise as antihypertensive lifestyle therapy, despite the fact our findings 
showed they are the patients who may benefit the most. Our findings highlight the critical need for a 
more individualized, possibly, race/ethnicity-specific approach to the Ex Rx for hypertension in order 
to maximize the effectiveness of exercise as antihypertensive therapy.  
Second, our meta-analyses gauged the individual study quality for each included trial using 
an augmented version of the Downs and Black Checklist [1, 2]. In addition, we quantitatively 
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incorporated methodological study quality and quality-related features of the exercise interventions 
(i.e., whether trials had BP-focused outcomes) to determine whether study quality independently [7, 
38] or interactively [39] modulated the BP response to exercise training. We, along with prior meta-
analyses [6, 7], have found the exercise and hypertension literature to be of ‘fair to moderate’ 
methodological quality [1, 2]. In the absence of a higher quality literature, there is the potential risk 
of bias or other threats to the validity of our findings. For this reason, we explored potential sources 
of bias related to the five quality subscales of the Downs and Black checklist, whether trials had BP-
focused outcomes, and whether the publication year, type of trial (i.e., RCT versus non-RCT), or 
number of funding sources influenced our results. We then statistically examined whether these 
potential sources of biases modulated the BP response to AET and dynamic RT, and even when these 
features were non-significant in bivariate meta-regression models, we incorporated them to control 
for confounding or suppression effects that could arise from lower-quality trials [7, 39].  
We found that higher study quality was associated with trials that: were published more 
recently (AET: r=0.15, p=0.03; RT: r=0.45, p<0.001), were RCTs (versus non-RCTs) (AET: 
r=0.36, p<0.001; RT: r=0.23, p=0.052), were adequately powered to detect BP outcomes (Downs 
and Black Checklist Item 28) (AET: r=0.26, p=0.09; RT: r=0.41, p<0.001), and followed standard 
protocols or established guidelines when measuring BP (i.e., American Heart Association Council on 
High BP Research Part 1: Recommendations for BP measurement in Humans [40]) (RT: r=0.24, 
p=0.045). Not surprisingly, trials that used standard protocols/established guidelines when assessing 
BP were more likely to have BP-focused outcomes (AET: r=0.22, p=0.002) and used more reliable 
and accurate BP assessment methods (Downs and Black Checklist Item 21) (r=0.19, p=0.006). 
Interestingly, trials that were adequately powered also had greater amounts of funding support (AET: 
r=0.68, p<0.001; RT: r=0.26, p=0.029). By examining the potential risk of bias from several sources 
and incorporating them into our multiple moderator models, we can be more confident in our study 
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results despite the number of methodological deficits and inconsistencies we have documented in this 
literature. 
4.5 Limitations 
 Despite our novel and important contributions, we identified other noteworthy gaps in the 
extant literature. Other than Whelton and colleagues [24], no previous meta-analysis until ours has 
documented race/ethnicity-dependent BP reductions following exercise training. Furthermore, 
Whelton et al. [24] only identified race/ethnicity as a moderator of the BP response to AET, whereas 
we found this moderation pattern persisted across modalities for both AET and RT. Unfortunately, 
included trials rarely disclosed the race/ethnicity of their participants; only 18% of AET [27-41] and 
14% of RT [22, 23, 42-48] trials reported this detail. Therefore, we employed the same strategy used 
by Whelton et al. [24] to estimate race/ethnicity when it was missing. It is well documented that 
certain racial/ethnic minority groups experience disproportionate health outcomes. Furthermore, 
there is a growing body of research that has documented the different physiological responses 
between ‘White’ and ‘non-White’ populations to the same exercise stimuli [41, 42], although the 
mechanisms to explain these differences have yet to be fully elucidated. In order to meaningfully 
contribute to this growing literature, a more comprehensive approach must be implemented for data 
collection at the primary-level to ensure that these important patient clinical characteristics are 
adequately reported.  
Although we identified FIT characteristics that moderated the BP response to AET and 
dynamic RT, we found that many important FIT characteristics and features of the exercise 
intervention were assessed using a variety of methods (i.e., lack of standardization in 
cardiorespiratory fitness and 1-RM testing procedures), and in many cases it was inconsistently 
reported or missing completely. Given that training adaptations are specific to the stimulus applied 
(i.e., principle of specificity), it is troubling that the majority of AET and RT trials failed to 
adequately report important features of the Ex Rx or properly assess training-induced changes in 
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physical function, fitness, and strength. Inconsistent reporting of these intervention characteristics not 
only precludes exercise professionals from identifying the optimal AET and RT Ex Rx FIT for adults 
with hypertension, but limits our ability to gauge how well participants tolerated the Ex Rx (i.e., 
exercise adherence), and ultimately, its effectiveness as antihypertensive therapy.  
Even though we examined several sources for potential biases, of which some addressed the 
validity of the BP assessment methods used, it important to reinforce the poor reporting of these 
variables in both the AET and RT literature. Several reviews [5-8] have commented on how the level 
of reporting and quality of BP assessment procedures may contribute to the discrepancies observed 
across studies in the magnitude of the BP reductions following exercise (i.e., unaccounted sources of 
heterogeneity). Yet, 38% of AET and 31% of RT interventions failed to disclose any BP assessment 
procedures, while ~20-30% of AET and RT trials failed to report specific details that included: the 
type of BP monitor or assessment tool (75-80% did), the body position during the BP measurement 
(69-72% did), and the timing of BP measurements at baseline (52-60% did) and post-intervention 
(17-20% did). At this time, it is unclear how the poor reporting and variability in these parameters 
influenced our results. 
Finally, many of the limitations noted above are exacerbated by the use of aggregated data 
(i.e., aggregate-level meta-analysis). Individual-participant data (IPD) meta-analysis is the 
(emerging) gold standard in meta-analytic practice [43, 44], although it is rarely used in the exercise 
and health promotion literature. IPD meta-analyses are superior to those performed with aggregated-
data because it avoids such issues as restriction in range of moderators (e.g. mean sample versus 
individual values that better capture the variability in training responses among samples) and 
ecological fallacy (e.g. assuming that all members of the exercise group benefit equally) [43, 45, 46]. 
On the other hand, IPD meta-analysis presents with a unique set of challenges, namely that it requires 
a greater time-commitment to obtain original, raw participant data from all relevant trials on specific 
topic [47, 48]. Furthermore, IPD approaches depend on collaborative efforts and the willingness of 
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researchers to share their data. If participant data is not available for all relevant trials, it is possible 
that the results will not be representative of the existing literature and lack generalizability to the 
population intended for treatment. Despite improved and likely greater precision in the analytic 
results from IPD meta-analyses, it is possible that aggregate-level meta-analyses are more 
appropriate to answer questions regarding the role of exercise training for the prevention, treatment 
and management of hypertension (i.e., Simpson’s paradox [49, 50]). The decision to use aggregated-
data versus IPD should be based on the most appropriate approach to answer the research question 
based on the available data with important consideration given to the strengths and weaknesses of 
their inherent assumptions [44, 45]. These steps, in addition to improved reporting transparency and 
adherence to contemporary methodological standards, should reduce the likelihood of Simpson’s 
Paradox [49, 50], that different trends will result from the application of different statistical analyses 
and partitioning of data.  
4.6 Strengths 
 Our meta-analyses had several strengths. The trial identification and selection process was 
comprehensive, and without restrictive inclusionary criteria that has been used in previously 
published meta-analyses. We strove to identify all potentially relevant reports from several electronic 
databases searched from their inception until our pre-specified end search date; we sought to locate 
reports in all languages regardless of publication status (i.e., our search permitted grey and 
unpublished literature), which yielded two of the largest meta-analyses conducted to date (86 AET 
trials,105 interventions; 64 RT trials, 71 interventions) [7]. We examined a priori, theoretically-
driven moderator analyses using more sophisticated [51, 52] and complex meta-analytic techniques 
[53], that until now have not been used to examine the antihypertensive effects of exercise. 
Consequently, our meta-analysis adhered to high-quality, contemporary methodological standards 
[54, 55] and completely satisfied the criteria implied by the PRISMA Statement (Preferred Reporting 
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Items for Systematic Review and Meta-Analyses) [54, 55] and the AMSTAR Scale (Assessment of 
Multiple SysTemAtic Reviews) [38, 56]. 
4.7 Conclusions 
In summary, our two high quality meta-analyses that adhered to contemporary 
methodological standards revealed several important findings. First, we confirmed that AET is 
effective antihypertensive therapy for adults with hypertension (~6-7 mmHg).  We found for the first 
time that high volume AET programs and large gains in physical fitness were associated with the 
largest BP reductions (~9-10 mmHg), most notably for non-White samples (~12 mmHg). These 
results indicate that the present exercise recommendations for hypertension should be revisited to 
include individualized, race/ethnicity-specific exercise prescription recommendations for populations 
who experience disproportionate adverse CVD outcomes, with the goal of improving physician-
patient interactions and adherence to exercise as lifestyle therapy.  
Second, we demonstrated that BP reductions following RT occurred in dose response fashion 
such that greater BP reductions occurred among samples with hypertension (~5-6 mmHg), which is 
comparable to the magnitude reported with AET. Samples with hypertension that performed ≥8 RT 
exercises per session, on 3-4 days∙wk-1 achieved the greatest BP reductions following RT (~9 
mmHg), notably among non-White samples (~10-14 mmHg). Our results indicate that the present 
exercise recommendations for hypertension should be revisited to include dynamic RT (in addition to 
AET) as stand-alone antihypertensive lifestyle therapy. 
Our findings suggest the following FITT-VP Ex Rx for the use of AET and dynamic RT as 
stand-alone antihypertensive therapy:  
Frequency: AET: 3-≥4 days·week-1, preferably most days of the week and dynamic RT: 3-4 
days·week-1  
Intensity: AET: Moderate-to-vigorous intensity (40->60% VO2peak; 3->6 MET). Progression to 
vigorous intensity AET may be warranted if the patient is willing and able to tolerate higher 
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levels of exertion. Dynamic RT: low-to-moderate intensity (~40-70% of 1-RM; 8-15RM; 3-<6 
MET) 
Time: AET: ~40 min∙session-1 and dynamic RT: ~3 sets of 10-12 repetitions for ~8-12 upper and 
lower body RT exercises lasting ~40 min∙session-1 to achieve a total amount of weekly exercise 
~120-200 min·week-1 
Type: AET: dynamic, aerobic activities such as walking, jogging, swimming, running, and cycling 
and dynamic RT: should target the major and can be performed using machine or free weights 
using a conventional or circuit-style training approach that target the major  muscle groups of 
the upper and lower body. Our meta-analysis examined the antihypertensive effects of isolated 
AET and RT, therefore it is unclear s how AET and dynamic RT should be combined as stand-
alone antihypertensive therapeutic exercise options. Further investigations are warranted to 
determine the optimal AET and RT FIT, specifically focused on whether AET and RT should 
be performed on the same (i.e., concurrently) or separate days (i.e., combined), and if 
concurrent exercise is most efficacious, further clarification is needed on whether AET should 
be performed before versus after or simultaneously (i.e., intermittent training) with RT.  
Volume: Moderate to high volumes of AET (~850 MET∙min∙week-1) and moderate volumes of 
dynamic RT (~575 MET∙min∙week-1) totaling ≥1200 MET∙min∙week-1 
Progression: In general, the special considerations already established in the ACSM’s guidelines 
for AET and dynamic RT still apply. The progression of AET and dynamic RT should be 
gradual, and tailored to individual patient’s ability and tolerance. 
Despite the promising and positive findings from our two meta-analyses, the AET and 
dynamic RT body of literature is of fair to moderate quality with other limitations noted within. 
Additional high-quality RCTs that have BP-focused outcomes are needed to investigate the 
antihypertensive effects of AET and RT as stand-alone or combined therapeutic exercise options 
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among more racially/ethnically diverse samples with hypertension. Future researchers should also 
incorporate standard assessment methodology for key variables, such as cardiorespiratory fitness, 
strength (1-RM), and manipulate the AET and RT FIT characteristics to further clarify the optimal 
‘dose’ of exercise to lower BP among adults with hypertension. 
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Appendix 1. Full search strategy used for electronic databases.   
Note. Full electronic search strategies for five databases, PubMed, Scopus (including EMBASE), 
Web of Science, SPORTDiscus, and CINAHL (Cumulative Index to Nursing and Allied Health 
Literature), are listed below. For each of the databases searched no start date was applied, and each 
database was searched from their inception or date of the earliest available publication.  
PubMed (including MEDLINE).  Hits = 8, 417 
Vendor/Platform: National Library of Medicine. Coverage: Date of inception 1940’s – January 31, 2014 
PubMed was searched with appropriate Medical Subject Headings (MeSH) incorporated into hedges. 
Filters were set for Humans: 
("mean arterial" OR "blood pressure"[mesh] OR "blood pressure" OR "blood pressures" OR "arterial 
pressure" OR "arterial pressures" OR hypertension OR hypotension OR normotension OR 
hypertensive OR antihypertensive OR hypotensive OR normotensive OR "systolic pressure" OR 
"diastolic pressure" OR "pulse pressure" OR "venous pressure" OR "pressure monitor" OR 
hypotension OR "pre hypertension" OR "bp response" OR "bp decrease" OR "bp reduction" OR "bp 
monitor" OR "bp monitors" OR "bp measurement")  
AND ("exercise"[majr] OR exercise[ti] OR exercises[ti]  OR exercising[ti] OR postexercise[ti]  OR 
running[mesh] OR running[ti] OR bicycling[mesh] OR bicycling OR bicycle* OR cycling[ti] OR 
treadmill* OR ergometer* OR "weight lifting" OR "weight training" OR "resistance training" OR 
"strength training" OR "endurance training" OR "speed training" OR "circuit training" OR "training 
duration" OR "training frequency" OR "training intensity" OR "aerobic endurance" OR "aerobic 
training" OR "interval training" OR "combination training" OR "combined training" OR 
plyometric* OR "HIIT" OR walking[mesh] OR walking[ti] OR swimming)  
AND ("randomized controlled trial"[pt] OR "controlled clinical trial"[pt] OR "random allocation" [mh] 
OR "clinical trial"[pt] OR "clinical trial"[tw] OR "latin square"[tw] OR random*[tw] OR "research 
design" [mh:noexp] OR "comparative study"[publication type] OR "evaluation studies"[publication 
type] OR "prospective studies" [mh] OR "cross-over studies" [mh] OR control[tw] OR 
controlled[tw])  
NOT ("DASH"[tiab] OR cancer OR neoplasms OR review[pt] OR fibromyalgia OR alzheimers OR 
alzheimer OR pregnant OR pregnancy OR "obesity/drug therapy"[mesh] OR pharmacol*[ti] OR 
drug[ti] OR pharmacist*[ti] OR "diet therapy"[mesh] OR "diet therapy"[subheading] OR 
"nutritional intervention" OR "dietary intervention" OR "nutritional counseling" OR "dietary 
counseling" OR caffeine OR "eating change" OR "activities of daily living" OR "dehydration" OR 
"dehydrate" OR "dehydrated" OR "dietary salt" OR sodium OR epilepsy OR influenza OR flu OR 
pneumonia OR septicemia OR arthritis OR hiv OR "Acquired Immunodeficiency Syndrome" OR 
meningitis OR "substance abuse" OR alcoholism OR "drug abuse" OR "Cross-Sectional 
Studies"[MeSH Terms] OR "Case Reports"[pt] OR Comment[pt] OR Editorial[pt] OR Letter[pt] OR 
Review[pt] OR "case control"[ti] OR "case report"[ti] OR "case study"[ti] OR "case series"[ti] OR 
"Case-Control Studies"[Mesh] OR "Follow-Up Studies"[Mesh] OR "observational study"[ti] OR 
"prospective cohort"[ti] OR "cohort studies" [Mesh:NoExp] OR "cohort study"[ti] OR "Longitudinal 
Studies" [Mesh:NoExp] OR "Follow-Up Studies"[mesh] OR "Retrospective Studies"[mesh] OR 
"follow up study"[ti] OR rat[ti] OR rats[ti] OR mice[ti] OR mouse[ti] OR dog[ti] OR dogs[ti] OR 
cats[ti] OR "epidemiology"[Subheading]) 
Scopus (including EMBASE).  Hits = 9, 354 
Vendor/platform: Elsevier SciVerse.  Coverage: Date of inception 1960 – January 31, 2014 
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Scopus was searched for the following terms in the “Article title, abstract, keywords.” Filters were set 
for Document Type, excluding: Review, Letter, Note, Editorial.   
Line 1 (in article, title, abstract, keywords): ({mean arterial} OR {blood pressure} OR {blood 
pressures} OR {arterial pressure} OR {arterial pressures} OR hypertension OR hypotension OR 
normotension OR hypertensive OR hypotensive OR normotensive OR {systolic pressure} OR 
{diastolic pressure} OR {pulse pressure} OR {venous pressure} OR {pressure monitor} OR 
hypotension OR {pre hypertension} OR {bp response} OR {bp decrease} OR {bp reduction} OR 
{bp monitor} OR {bp monitors} OR {bp measurement})  
AND Line 2 (in article, title, abstract, keywords): (bicycling OR bicycle* OR treadmill* OR 
ergometer* OR {weight lifting} OR {weight training} OR {resistance training} OR {strength 
training} OR {endurance training} OR {speed training} OR {circuit training} OR {training 
duration} OR {training frequency} OR {training intensity} OR {aerobic endurance} OR {aerobic 
training} OR {interval training} OR {combination training} OR {combined training} OR 
plyometric* OR HIIT OR swimming)  
OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR 
cycling OR walking)  
AND Line 4 (in article, title, abstract, keywords): ({clinical trial} OR {latin square} OR random* 
OR {comparative study} OR {evaluation study} OR {evaluative study} OR {prospective study} OR 
{cross-over study} OR control OR controlled)  
NOT Line 5 (in article, title, abstract, keywords): (DASH OR cancer OR neoplasms OR 
fibromyalgia OR alzheimer* OR pregnant OR pregnancy OR {nutritional intervention} OR {diet 
therapy} OR {dietary intervention} OR {nutritional counseling} OR {dietary counseling} OR 
caffeine OR {eating change} OR {activities of daily living} OR dehydration OR dehydrate OR 
dehydrated OR {dietary salt} OR sodium OR epilepsy OR influenza OR flu OR pneumonia OR 
septicemia OR arthritis OR hiv OR {Acquired Immunodeficiency Syndrome} OR meningitis OR 
{substance abuse} OR alcoholism OR {drug abuse}) 
OR Line 6 (in article title): (review OR pharmacol* OR drug OR pharmacist* OR {cross-sectional} 
OR {case report} OR comment OR commentary OR editorial OR letter OR {case control} OR {case 
study} OR {case series} OR {follow-up study} OR {observational study} OR {prospective cohort} 
OR {cohort study} OR {longitudinal study} OR {retrospective study} OR rat OR rats OR mice OR 
mouse OR dog OR dogs OR cats OR {epidemiology}) 
Web of Science (also known as Web of Knowledge).  Hits = 3, 658 
Vendor/platform: Thomson Reuters.  Coverage: Earliest date available 1974 – January 31, 2014 
Web of Science was searched using the following terms as “Topic” words. Filters were set for 
Document Type, including only: Articles, Proceedings Papers. Due to database limitations, excluded 
terms (i.e., “NOT” terms) were only searched in the article titles, and was performed using 
RefWorks. 
Line 1 (in topic): ("mean arterial" OR "blood pressure" OR "blood pressures" OR "arterial pressure" 
OR "arterial pressures" OR hypertension OR hypotension OR normotension OR hypertensive OR 
hypotensive OR normotensive OR "systolic pressure" OR "diastolic pressure" OR "pulse pressure" 
OR "venous pressure" OR "pressure monitor" OR hypotension OR "pre hypertension" OR "bp 
response" OR "bp decrease" OR "bp reduction" OR "bp monitor" OR "bp monitors" OR "bp 
measurement")  
AND Line 2 (in topic): (bicycling OR bicycle* OR treadmill* OR ergometer* OR "weight lifting" OR 
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"weight training" OR "resistance training" OR "strength training" OR "endurance training" OR 
"speed training" OR "circuit training" OR "training duration" OR "training frequency" OR "training 
intensity" OR "aerobic endurance" OR "aerobic training" OR "interval training" OR "combination 
training" OR "combined training" OR plyometric* OR HIIT OR swimming)  
OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR 
cycling OR walking)  
AND Line 4 (in topic): ("clinical trial" OR "latin square" OR random* OR "comparative study" OR 
"evaluation study" OR "evaluative study" OR "prospective study" OR "cross-over study" OR control 
OR controlled)  
NOT Line 5 (in title): (DASH OR cancer OR neoplasms OR fibromyalgia OR alzheimer* OR 
pregnant OR pregnancy OR "nutritional intervention" OR "diet therapy" OR "dietary intervention" 
OR "nutritional counseling" OR "dietary counseling" OR caffeine OR "eating change" OR 
"activities of daily living" OR dehydration OR dehydrate OR dehydrated OR "dietary salt" OR 
sodium OR epilepsy OR influenza OR flu OR pneumonia OR septicemia OR arthritis OR hiv OR 
"Acquired Immunodeficiency Syndrome" OR meningitis OR "substance abuse" OR alcoholism OR 
"drug abuse" OR review OR pharmacol* OR drug OR pharmacist* OR "cross-sectional" OR "case 
report" OR comment OR commentary OR editorial OR letter OR "case control" OR "case study" 
OR "case series" OR "follow-up study" OR "observational study" OR "prospective cohort" OR 
"cohort study" OR "longitudinal study" OR "retrospective study" OR rat OR rats OR mice OR 
mouse OR dog OR dogs OR cats OR "epidemiology") 
SPORTDiscus. Hits = 537 
Vendor/platform: EbscoHost.  Coverage: Date of inception 1975 – January 31, 2014 
SportDiscus was searched for the following terms as “Topic” words.  Filters were set for Publication 
Type, including only: Journal Articles; Peer Reviewed; Academic Journals: 
Line 1: ("mean arterial" OR "blood pressure" OR "blood pressures" OR "arterial pressure" OR "arterial 
pressures" OR hypertension OR hypotension OR normotension OR hypertensive OR hypotensive 
OR normotensive OR "systolic pressure" OR "diastolic pressure" OR "pulse pressure" OR "venous 
pressure" OR "pressure monitor" OR hypotension OR "pre hypertension" OR "bp response" OR "bp 
decrease" OR "bp reduction" OR "bp monitor" OR "bp monitors" OR "bp measurement")  
AND Line 2: (bicycling OR bicycle* OR treadmill* OR ergometer* OR "weight lifting" OR "weight 
training" OR "resistance training" OR "strength training" OR "endurance training" OR "speed 
training" OR "circuit training" OR "training duration" OR "training frequency" OR "training 
intensity" OR "aerobic endurance" OR "aerobic training" OR "interval training" OR "combination 
training" OR "combined training" OR plyometric* OR HIIT OR swimming)  
OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR 
cycling OR walking)  
AND Line 4: ("clinical trial" OR "latin square" OR random* OR "comparative study" OR "evaluation 
study" OR "evaluative study" OR "prospective study" OR "cross-over study" OR control OR 
controlled)  
NOT Line 5 (in title): (DASH OR cancer OR neoplasms OR fibromyalgia OR alzheimer* OR 
pregnant OR pregnancy OR "nutritional intervention" OR "diet therapy" OR "dietary intervention" 
OR "nutritional counseling" OR "dietary counseling" OR caffeine OR "eating change" OR 
"activities of daily living" OR dehydration OR dehydrate OR dehydrated OR "dietary salt" OR 
sodium OR epilepsy OR influenza OR flu OR pneumonia OR septicemia OR arthritis OR hiv OR 
"Acquired Immunodeficiency Syndrome" OR meningitis OR "substance abuse" OR alcoholism OR 
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"drug abuse" OR review OR pharmacol* OR drug OR pharmacist* OR "cross-sectional" OR "case 
report" OR comment OR commentary OR editorial OR letter OR "case control" OR "case study" 
OR "case series" OR "follow-up study" OR "observational study" OR "prospective cohort" OR 
"cohort study" OR "longitudinal study" OR "retrospective study" OR rat OR rats OR mice OR 
mouse OR dog OR dogs OR cats OR "epidemiology") 
CINAHL: Cumulative Index to Nursing and Allied Health Literature.  Hits = 122 
Vendor/Platform: EbscoHost.  Coverage: Date of inception 1981 – January 31, 2014  
CINAHL was searched with appropriate CINAHL subject headings incorporated into hedges, though 
not shown below, medical headings were included for “blood pressure”, “exercise”, “running”, and 
“weight lifting”.  Filters were set for Research Article; Humans, All Adults. CINAHL hits excluded 
MEDLINE records.  
Line 1: ("mean arterial" OR "blood pressure" OR "blood pressures" OR "arterial pressure" OR "arterial 
pressures" OR hypertension OR hypotension OR normotension OR hypertensive OR hypotensive 
OR normotensive OR "systolic pressure" OR "diastolic pressure" OR "pulse pressure" OR "venous 
pressure" OR "pressure monitor" OR hypotension OR "pre hypertension" OR "bp response" OR "bp 
decrease" OR "bp reduction" OR "bp monitor" OR "bp monitors" OR "bp measurement")  
AND Line 2: (bicycling OR bicycle* OR treadmill* OR ergometer* OR "weight lifting" OR "weight 
training" OR "resistance training" OR "strength training" OR "endurance training" OR "speed 
training" OR "circuit training" OR "training duration" OR "training frequency" OR "training 
intensity" OR "aerobic endurance" OR "aerobic training" OR "interval training" OR "combination 
training" OR "combined training" OR plyometric* OR HIIT OR swimming)  
OR Line 3 (in article title): (exercise OR exercises OR exercising OR postexercise OR running OR 
cycling OR walking)  
AND Line 4: ("clinical trial" OR "latin square" OR random* OR "comparative study" OR "evaluation 
study" OR "evaluative study" OR "prospective study" OR "cross-over study" OR control OR 
controlled)  
NOT Line 5 (in title): (DASH OR cancer OR neoplasms OR fibromyalgia OR alzheimer* OR 
pregnant OR pregnancy OR "nutritional intervention" OR "diet therapy" OR "dietary intervention" 
OR "nutritional counseling" OR "dietary counseling" OR caffeine OR "eating change" OR 
"activities of daily living" OR dehydration OR dehydrate OR dehydrated OR "dietary salt" OR 
sodium OR epilepsy OR influenza OR flu OR pneumonia OR septicemia OR arthritis OR hiv OR 
"Acquired Immunodeficiency Syndrome" OR meningitis OR "substance abuse" OR alcoholism OR 
"drug abuse" OR review OR pharmacol* OR drug OR pharmacist* OR "cross-sectional" OR "case 
report" OR comment OR commentary OR editorial OR letter OR "case control" OR "case study" 
OR "case series" OR "follow-up study" OR "observational study" OR "prospective cohort" OR 
"cohort study" OR "longitudinal study" OR "retrospective study" OR rat OR rats OR mice OR 
mouse OR dog OR dogs OR cats OR "epidemiology") 
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Appendix 2. Reference list for the included aerobic exercise training trials (n=84). Aerobic 
exercise training studies with >1 independent interventions (n=6) are bolded below (k=90 
interventions).   
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Appendix 3. Augmented version of the Downs and Black Checklist. 
Individual Study Quality Items, Listed by Quality Subscale  Y N U/D P 
1. Is the hypothesis/aim/objective of the study clearly described? †  1 0 0 — 
2. Are the main outcomes to be measured clearly described in the Introduction or Methods section? †  1 0 0 — 
3. Is BP a primary outcome? *  1 0 0 ½ 
4. Are the characteristics of the study population included in the study clearly described? ‡  1 0 0 ½ 
5. Are the interventions under study clearly described? ‡  1 0 0 ½ 
6. Are the distributions of principal confounders in each intervention clearly described? †  1 0 0 ½ 
7. Are the BP findings of the study clearly described? §  1 0 0 — 
8. Are estimates of the random variability (e.g., SE, SD, CIs, etc.) for BP outcomes reported? §  1 0 0 — 
9. Have all important adverse events/negative outcomes that may be a consequence of the intervention 
been reported? If eligibility screening was reported, award partial score. ‡ 
 
1 0 0 ½ 
10. Have the characteristics of study participants lost to follow up been described? †  1 0 0 — 
11. Are actual values reported (e.g., 0.035 vs. <0.05) for BP outcomes except for values <0.001? §  1 0 0 — 
Reporting                                                                    Items satisfied=___ (11 possible points)     
12. Were study subjects asked to participate representative of the population they were recruited? †  1 0 0 — 
13. Were study subjects who agreed to participate representative of the population they were 
recruited? † 
 
1 0 0 — 
14. Were the staff, places, and facilities where the study subjects received the intervention 
representative of the intervention the majority of subjects receive? † 
 
1 0 0 — 
External Validity                                                          Items satisfied=___ (3 possible points)     
15. Were subjects “blinded” to their assigned intervention until recruitment and baseline/pre-training 
measurements were completed and final? (i.e., subjects were unaware of the intervention they had 
received until these processes were complete). § 
 
1 0 0 — 
16. Was an attempt made to blind those measuring BP outcomes of the intervention? §  1 0 0 — 
17. If any of the results of the study were based on “data dredging”, was this made clear? †  1 0 0 — 
18. In trials and cohort studies, do analyses adjust for different follow-up lengths for participants, or is 
the time period between the intervention and outcome the same for cases and controls? † 
 
1 0 0 — 
19. Were the statistical tests used to assess the main outcomes appropriate? †  1 0 0 — 
20. Was compliance with the intervention reliable based on reported exercise adherence, level of 
supervision, or use of monitoring devices? § 
 
1 0 0 — 
21. Were the BP measures accurate? (i.e., were measures of resting BP and/ or ambulatory BP valid 
and reliable based on the tool(s) and procedures?) § 
 
1 0 0 ½ 
Internal Validity – Bias                                               Items satisfied=___ (7 possible points)      
22. Were study participants in the different intervention groups (trials and cohort studies) or were the 
cases and controls (case-control studies) recruited from the same population? † 
 
1 0 0 — 
23. Were study participants in the different intervention groups (trials and cohort studies) or were the 
cases and controls (case-control studies) recruited over the same period of time? † 
 
1 0 0 — 
24. Were study participants randomized to intervention groups? †  1 0 0 ½ 
25. Was the randomized intervention assignment concealed from both study participants and 
intervention staff until recruitment was complete and irrecoverable? † 
 
1 0 0 — 
26. Was there adequate adjustment in analyses for confounding from which the main findings were 
drawn? † 
 
1 0 0 — 
27. Were losses of study participants to follow-up taken into account? †  1 0 0 — 
Internal Validity – Confounding                                 Items satisfied=___ (6 possible points)     
28. Was a power analysis conducted to determine the sample size needed to detect a significant 
difference(s) in effect size for the BP or other outcome measure(s)? § 
 
1/2 0 0 — 
Power                                                                            Items satisfied=___ (2 possible points)     
Total Study Quality Score =______ of 29 possible points (sum of all subscale scores)       
Note. BP=Blood pressure. N=No, not satisfied. P=Partially satisfied. U/D=Unable to determine. Y=Yes, fully 
satisfied. *New item (not part of original checklist). † Original item. ‡ Clarified from original checklist. § 
Modified from original checklist. 
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Appendix 4. Methods used to calculate the standardized mean difference effect size (ES) 
estimations (and their components), and the unstandardized or raw metric (i.e., mmHg) for 
different study designs. 
1. The standardized mean difference ES estimate for two independent groups (i.e., parallel study design; 
between-group ES) with a repeated-measures design (i.e., post- versus pre-intervention): Becker’s d 
[1-3]: 
  ,      
Note. c(N−2)=Correction factor for small sample size bias and baseline differences, where  
N=n
E
post + n
C
post  (i.e., the total number of participants in the exercise and control groups post-
intervention). ?̅?Post; Pre=Mean blood pressure for the sample taken at post- and pre-intervention. 
E=Exercise group. C=Non-exercise control group. Spre=Standard deviation of the pre-intervention blood 
pressure for the exercise and control group.  
 
2. The standardized mean difference ES estimate for a one-group (i.e., cross-over study design; within-
group ES) repeated-measures design (i.e., post- versus pre-intervention): Becker’s d [1-3] 
  ,       
Note. c(n−1)=Correction factor for small sample size bias and baseline differences, where n=the number 
of participants post-intervention for the exercise or control group. ?̅?Post; Pre=Mean blood pressure for the 
sample taken at post- and pre-intervention. Spre=Standard deviation of the pre-intervention blood pressure 
for the exercise or control group. 
3. The unstandardized mean difference ES estimate for two independent groups (i.e., parallel study 
design; between-group ES) with a repeated-measures design (i.e., post- versus pre-intervention) 
provided in the raw metric (mmHg) [2-4]: 
𝑅𝑎𝑤 𝐸𝑆 (𝑚𝑚𝐻𝑔) 𝑈𝑀𝐷 = [(Y̅Post
 E
‒ Y̅Pre
 E
)─ (Y̅Post
 C
 ‒ Y̅Pre
 C
)] , weighted by the inverse variance of the  
𝑅𝑎𝑤 𝐸𝑆 (𝑚𝑚𝐻𝑔) 𝑈𝑀𝐷: , where  
Note. UMD=Unstandardized mean difference. ?̅?Post − ?̅?Pre=Difference in blood pressure (mmHg) taken at 
post- and pre-intervention for the Exercise (E) and Control (C) groups.  
1
𝑉𝑎𝑟𝑈𝑀𝐷
 =Inverse variance of the 
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UMD. n
E
=number of participants in the exercise group post-intervention. n
C
=number of participants in 
the control group post-intervention. Spooled=Pooled standard deviation. SE=Standard deviation of the post-
intervention blood pressure for the exercise group. S
C
=Standard deviation of the post-intervention blood 
pressure for the control group. 
4. The unstandardized mean difference ES estimate for a one-group (i.e., cross-over study design; 
within-group ES) repeated-measures design (i.e., post- versus pre-intervention) provided in the raw 
metric (mmHg) [2-4]: 
𝑅𝑎𝑤 𝐸𝑆 (𝑚𝑚𝐻𝑔) 𝑈𝑀𝐷 = [(Y̅Post
 
 ‒ Y̅Pre
 
)] , weighted by the inverse variance of the 
𝑅𝑎𝑤 𝐸𝑆 (𝑚𝑚𝐻𝑔) 𝑈𝑀𝐷: 
1
Var
UMD
=
n
Spost (n)
  
Note. UMD=Unstandardized mean difference. ?̅?Post − ?̅?Pre=Difference in the sample’s blood pressure 
(mmHg) taken at post- and pre-intervention. n=number of participants post-intervention. 
1
𝑉𝑎𝑟𝑈𝑀𝐷
 =Inverse 
variance of the UMD. Spost=Standard deviation of the sample’s post-intervention blood pressure. 
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Appendix 9. Summary of resting and ambulatory blood pressure assessment 
techniques pre- and post-intervention (k=90). 
Assessment Technique  k  Mean ± sd  Range 
BP Assessment Procedures   56  62.2%   
Gold Standard Followed  10  11.1%  — 
Some Procedures Disclosed  46  51.1%  — 
No Procedures Disclosed  34  37.8%  — 
Timing of BP Measurements  59  65.6%   
Pre-intervention: Seated or supine rest preceding 
baseline reading (minutes) 
 55  13.3 ± 10.5  3.0, 60.0 
Post-intervention: duration (hours) between last 
exercise bout and post-BP reading 
 15  67.2 ± 44.4  24.0, 168.0 
Less than 48 hours  2  30.0 ± 8.5  24.0, 36.0  
≥48 to 96 hours   10  51.6 ± 11.4  48.0, 84.0 
≥96 hours  3  144.0 ± 41.6  96.0, 168.0 
Body Position  65  72.2%  — 
Seated  44  67.7%  — 
Supine  21  32.3%  — 
BP Monitor/Assessment Tool  68  75.6%  — 
Manual sphygmomanometer  36  52.9%  — 
Random-zero   10  14.7%  — 
Mercury  17  25.0%  — 
“Standard aneroid”   9  13.2%  — 
Automated  21  30.9%  — 
Semi-automated/oscillometric device  11  16.2%  — 
Ambulatory BP Monitoring   9  13.2%  — 
Ambulatory BP Monitoring Period (hours)   9  19.3 ± 5.9  8.0, 24.0 
24-Hour *  4  44.4%  — 
Awake/Daytime †  8  9.9 ± 3.9  6.0, 16.0 
Sleep/Nighttime ‡  6  11.8 ± 3.8  7.0, 16.0 
Note. k=number of interventions. Statistics are presented as Mean ± Standard deviation (sd) 
unless otherwise stated; Range=Minimum, Maximum. BP=Blood pressure. * 24-Hour [18, 
55, 73]; 3 trials reported 24-hour ambulatory BP monitoring; yet BP data was collected over 
22 [40] and 18 hours [43, 79]. † Daytime (“awake”) hours [7, 12, 18, 40, 43, 55, 79].  
‡ Nighttime (“sleep”) hours [40, 43, 55, 79]; Gilders et al. [18] reported ABP data in three 8 
hour segments (daytime, evening, nighttime); evening and nighttime were combined.  
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Appendix 11. Figure S1. Tests for publication bias: Unadjusted Begg and Egger funnel plots 
and adjusted funnel plot (via trim and fill procedures).  
Note. Data points in the unadjusted plots are weighted and sized proportional to the inverse variance. 
 
Systolic blood pressure: Aerobic exercise training versus non-exercise control: 
Unadjusted Begg and Egger Plots:  
 
 
Begg's funnel plot with pseudo 95% confidence limits
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Adjusted Funnel Plot (Trim and Fill): 7 iterations “trimmed” and the “filled” analysis was 
based on k=120 versus k=105 comparisons 
 
 
Diastolic blood pressure: Aerobic exercise training versus non-exercise control 
Unadjusted Begg and Egger Plots: 
 
Filled funnel plot with pseudo 95% confidence limits
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Adjusted Funnel Plot (Trim and Fill): 8 iterations “trimmed” and the “filled” analysis was 
based on k=109 versus k=101 comparisons  
 
 
 
  
Egger's publication bias plot
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Appendix 16. A summary of the dynamic resistance training intervention 
characteristics (k=71). 
Program Characteristics    k  Mean ± sd  Range   Median 
Participants (n) at baseline   71  21.1 ± 14.9  8.0, 72.0  15.0 
Participants (n) post-RT   71  18.4 ± 11.4  8.0, 60.0  14.0 
Attrition in RT group (%)  71  8.5 ± 13.1   0.0, 53.0  0.0 
Exercise Adherence (%)  46  92.3 ± 8.9   60.0, 100.0  95.0 
Dynamic RT Program        
Length (weeks)  71  14.4 ± 7.9   6.0, 48.0  12.0 
Frequency (days·week-1)  71  2.8 ± 0.6   2.0, 5.0  3.0 
 * Intensity or Load (% 1-RM)  63  67.2 ± 12.4   30.0, 100.0  70.0 
† Estimated MET   71  4.7 ± 1.8   2.8, 8.5  3.8 
Percentage of 1-RM (%)  38  64.7 ± 13.0  30.0, 87.5  65.0 
MVC (%)  2  90.0 ± 14.4  80.0, 100.0   
10-15 RM  8  12.6%    
8-12 RM  8  12.5%    
6-16 RM  2  3.1%    
OMNI-RT Scale  2  3.1%    
Theraband (not specified)  3  4.7%    
Time (total work∙session-1)        
Number of exercises∙session-1  69  7.9 ± 2.9   1.0, 16.0  7.0 
Number sets∙exercise-1  67  2.8 ± 0.9   1.0, 5.0  3.0 
Number reps∙set-1  65  11.0 ± 3.8   5.0, 30.0  10.0 
Rest interval between sets (s)  30  96.3 ± 43.3   15.0, 180.0  90.0 
Type of RT         
Conventional RT  54  76.0%     
Circuit-style RT   10  14.3%     
Therabands (i.e., elastic bands)  4  5.7%     
Ankle or shin weights   2  2.9%     
Muscle Groups Targeted         
Upper and Lower Body   63  91.3%     
Lower Body   4  5.8%     
Unilateral, Upper Body  2  2.9%     
Note. k=number of observations. Abbr. MVC=Maximum voluntary contraction. MET= 
Metabolic equivalent unit. Range=Minimum, Maximum values. Reps=Repetitions. RM= 
Repetition maximum. RT=Resistance training. s=seconds. %=Percentage. * When RT 
load was reported as MVC or 1-RM range, % of 1-RM was estimated and combined with 
trials that reported 1-RM (%). † When RT was unreported (k=12) or quantified in other 
units (k=39), % of 1-RM was estimated using a standardized unit (i.e., MET). 
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Appendix 17. Summary of the resting blood pressure assessment techniques pre-and 
post-intervention (k=71). 
Assessment Technique  k  Mean ± sd  Range 
BP Assessment Procedures   49  69.0%  — 
Gold Standard Followed  12  16.9%  — 
Some Procedures Disclosed  37  52.1%  — 
No Procedures Disclosed  22  31.0%  — 
Timing of BP Measurements       
Pre-intervention: Seated or supine rest 
preceding baseline reading (min) 
 37  10.3 ± 5.5  5.0, 25.0 
Post-intervention: duration (hr) between last 
exercise bout and post-BP reading 
 14  79.9 ± 59.1  20.0, 192.0 
Less than 24 hr  4  21.5 ±1.0  20.0, 22.0  
24 to 48 hr   3  48.0 ± 0.0  — 
>48 to 96 hr  2  84.0 ± 17.0  72.0, 96.0 
>96 hr  5  144.0 ± 44.1  108.0, 192.0  
Body Position  49  69.0%  — 
Seated  30  61.2%  — 
Supine  19  38.8%  — 
Number of BP Readings  43  3.1 ± 1.1  2.0, 6.0 
BP Monitor/ Assessment Tool  58  81.7%  — 
Manual sphygmomanometer  29  40.8%  — 
Random-zero  3  5.2%  — 
Mercury  11  19.0%  — 
“Standard aneroid”   15  25.9%  — 
Automated  16  27.6%  — 
Semi-automated/oscillometric device  13  22.4%  — 
Ambulatory BP Monitor  2  4.1%  — 
Note. k=number of observations. Statistics are presented as Mean ± Standard deviation  
(sd) unless otherwise stated; Range=Minimum, Maximum. BP=Blood pressure. 
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Appendix 19. Figure S3. Tests for publication bias: Funnel plots using Begg and Egger 
methods. Note. Data points are weighted and sized proportional to the inverse variance.  
 
Systolic blood pressure: Dynamic resistance training versus non-exercise control 
           
 
 
 
 
  
Begg's funnel plot with pseudo 95% confidence limits
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Diastolic blood pressure: Dynamic resistance training versus non-exercise control 
           
 
 
 
 
 
Begg's funnel plot with pseudo 95% confidence limits
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Appendix 20. Figure S4. Contour-enhanced funnel plots (i.e., confunnels): A visual 
representation of the effect size distribution (the standardized mean difference, d+) for the 
antihypertensive effects of dynamic resistance training versus non-exercise control. 
 
Systolic Blood Pressure 
 
 
Diastolic Blood Pressure 
 
 
Note. Weighted mean effect size values (d+) are negative when dynamic resistance training reduced 
blood pressure to a greater extent than control. The blue line and arrowhead indicates the overall 
mean effect size. 
 
